NanoFlex Power (OPVS) 10-K 15 Mar 17 2016 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2016	Mar. 13, 2017	Jun. 30, 2016
Document and Entity Information [Abstract]
Entity Registrant Name	NanoFlex Power Corp
Entity Central Index Key	1,571,636
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Type	10-K
Document Period End Date	Dec. 31, 2016
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2,016
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Smaller Reporting Company
Entity Public Float			$ 11,778,232
Entity Common Stock, Shares Outstanding		60,771,521

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Dec. 31, 2016	Dec. 31, 2015
Current assets:
Cash	$ 2,986	$ 6,255
Accounts receivable		95,623
Prepaid expenses and other current assets	20,105	854
Total current assets	23,091	102,732
Property and equipment, net	6,942	13,735
Total assets	30,033	116,467
Current liabilities:
Accounts payable	3,388,189	3,341,905
Accounts payable- related party	2,470	62,469
Accrued expenses	1,200,544	1,840,537
Warrant derivative liability	8,828,405	12,796,146
Conversion option derivative liability	3,156,736	5,411,187
Short-term debt, net of unamortized discounts	243,208	150,000
Short-term debt- related party, net of unamortized discounts	500,000	670,848
Convertible debt, net of unamortized discounts	1,440,206	1,123,818
Advances - related party	510,000	110,000
Total current liabilities	19,269,758	25,506,910
Total liabilities	19,269,758	25,506,910
Stockholders' deficit:
Common stock, 500,000,000 authorized, $0.0001 par value, 60,263,720 and 51,473,157 issued and outstanding as of December 31, 2016 and December 31, 2015, respectively	6,026	5,148
Additional paid-in capital	189,324,088	176,108,887
Accumulated deficit	(208,569,839)	(201,504,478)
Total stockholders' deficit	(19,239,725)	(25,390,443)
Total liabilities and stockholders' deficit	$ 30,033	$ 116,467

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - $ / shares	Dec. 31, 2016	Dec. 31, 2015
Statement of Financial Position [Abstract]
Common Stock, shares authorized	500,000,000	500,000,000
Common Stock, par value per share	$ 0.0001	$ 0.0001
Common Stock, shares issued	60,263,720	51,473,157
Common stock, shares outstanding	60,263,720	51,473,157

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Statements of Operations [Abstract]
Revenue	$ 115,400	$ 119,998
Cost of services	(458,576)	(114,947)
Gross loss	(343,176)	5,051
Operating expenses:
Research and development	1,683,464	2,325,539
Patent application and prosecution fees	1,525,695	1,724,988
Selling, general and administrative expenses	2,930,222	7,018,803
Total operating expenses	6,139,381	11,069,330
Loss from operations	(6,482,557)	(11,064,279)
Other income (expenses):
Gain (loss) on change in fair value of derivative	7,326,535	(10,193,218)
Loss on extinguishment of debt	(3,756,986)	(150,000)
Interest expense	(4,152,353)	(1,909,022)
Total other income (expense)	(582,804)	(12,252,240)
Net loss	$ (7,065,361)	$ (23,316,519)
Net loss per common share:
Basic and diluted	$ (0.12)	$ (0.49)
Weighted average common shares outstanding:
Basic and diluted	57,766,386	47,893,197

Consolidated Statements of Chan

Consolidated Statements of Changes in Stockholders' Deficit - USD ($)	Total	Common Stock	Additional Paid in Capital	Accumulated Deficit
Beginning balance at Dec. 31, 2014	$ (6,044,343)	$ 4,431	$ 172,139,185	$ (178,187,959)
Beginning balance (in shares) at Dec. 31, 2014		44,306,278
Warrants exercised for cash	914,220	$ 183	914,037
Warrants exercised for cash (in shares)		1,828,437
Conversion of debt and interest to common stock and warrants	1,661,615	$ 332	1,661,283
Conversion of debt and interest to common stock and warrants, shares		3,323,230
Common stock and warrants issued for cash	136,000	$ 19	135,981
Common stock and warrants issued for cash, shares		186,000
Warrants issued for interest expense
Warrants reclassified as derivative liabilities	(76,368)		(76,368)
Warrants issued for services	4,615,154		4,615,154
Beneficial conversion feature and warrants issued with debt	1,655,369		1,655,369
Options issued for services	364		364
Common stock returned and cancelled for issuance of convertible note	(37,644)	$ (7)	(37,637)
Common stock returned and cancelled for issuance of convertible note, shares		(75,288)
Common stock issued for services	350,000	$ 35	349,965
Common stock issued for services (in shares)		350,000
Additional common shares issued related to warrant reset		$ 155	(155)
Additional common shares issued related to warrant reset, shares		1,554,500
Warrants issued upon conversion of debt	494,730		494,730
Convertible debt reclassified as derivative liabilities	(5,743,021)		(5,743,021)
Net loss	(23,316,519)			(23,316,519)
Ending balance at Dec. 31, 2015	(25,390,443)	$ 5,148	72,191	(201,504,478)
Ending balance (in shares) at Dec. 31, 2015		51,473,157
Warrants exercised for cash	72,205	$ 14	72,191
Warrants exercised for cash (in shares)		144,411
Conversion of debt and interest to common stock and warrants	3,483,101	$ 696	3,482,405
Conversion of debt and interest to common stock and warrants, shares		6,966,199
Common stock and warrants issued for cash	663,922	$ 143,000	663,779
Common stock and warrants issued for cash, shares		1,434,076
Common stock and warrants issued for extinguishment of liability	617,175	$ 25	617,150
Common stock and warrants issued for extinguishment of liability, shares		245,878
Warrants issued for interest expense	6,023		6,023
Warrants reclassified as derivative liabilities	(559,900)		(559,900)
Warrants issued for services	1,956,619		1,956,619
Beneficial conversion feature and warrants issued with debt	4,676,812		4,676,812
Warrants issued for debt modification	2,280,965		2,280,965
Options issued for services	19,157		19,157
Net loss	(7,065,361)			(7,065,361)
Ending balance at Dec. 31, 2016	$ (19,239,725)	$ 6,026	$ 189,324,088	$ (208,569,839)
Ending balance (in shares) at Dec. 31, 2016		60,263,721

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (7,065,361)	$ (23,316,519)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense	6,793	5,785
Warrants issued as compensation	1,956,619	4,615,154
Options issued as compensation	19,157	364
Common shares issued for services		350,000
Interest expense of warrants related to conversion of debt	1,297,324	494,730
Amortization of debt discounts	2,442,475	1,292,525
Loss on extinguishment of debt	3,756,986	150,000
Warrants issued for interest expense	6,023
Derivative warrant issued for services	544,443	1,346,935
(Gain) loss on change in fair value of derivative liabilities	(7,326,535)	10,193,218
Changes in operating assets and liabilities:
Prepaid expenses and other current assets	(19,251)	4,665
Accounts receivable	95,623	(95,623)
Accounts payable	46,284	1,483,994
Accounts payable - related party	(59,999)	14,405
Accrued expenses	(322,977)	(41,179)
Net cash used in operating activities	(4,622,396)	(3,501,546)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchases of fixed assets		(5,842)
Net cash used in investing activities		(5,842)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from sale of common shares and warrants	663,922	136,000
Proceeds from exercise of warrants	72,205	914,220
Borrowings on short-term debt	300,000
Proceeds from short-term debt		50,000
Borrowings on related party debt	1,875,000	625,000
Payments on related party debt	(150,000)
Borrowings on convertible debt	1,458,000	2,106,405
Advances received from related party	730,000	212,350
Advances repaid to related party	(330,000)	(530,500)
Net cash provided by financing activities	4,619,127	3,513,475
NET INCREASE (DECREASE) IN CASH	(3,269)	6,087
Cash, beginning of the period	6,255	168
Cash, end of the period	2,986	6,255
SUPPLEMENTAL CASH FLOW INFORMATION
Cash paid for interest	16,678	11,984
Cash paid for income taxes
NON-CASH INVESTING AND FINANCING ACTIVITIES
Principal and interest converted into common stock	3,483,101
Common stock and warrants issued for accrued interest		26,687
Common stock and warrants issued for debt		1,634,928
Debt discount due to warrants issued with promissory notes	1,231,366
Debt discount on beneficial conversion feature and warrants issued with convertible debt	2,148,122	1,655,369
Accrued liabilities settled with common shares and warrants	67,536
Reclassification of conversion option as derivative liabilities		5,743,021
Reclassification of warrants as derivative liabilities	559,900	76,368
Note modified to be convertible note and then converted	2,050,000
Accrued interest converted to debt		50,000
Issuance of common stock related to PIPE II anti-dilution provision		155
Common stock returned and cancelled for issuance of convertible notes		$ 37,644

Background, Basis of Presentati

Background, Basis of Presentation	12 Months Ended
	Dec. 31, 2016
Background, Basis of Presentation [Abstract]
Background, Basis of Presentation	Note 1: Background, Basis of Presentation: Background NanoFlex Power Corporation, formerly known as Universal Technology Systems, Corp., was incorporated in the State of Florida on January 28, 2013. On September 24, 2013, the Company completed the acquisition of Global Photonic Energy Corporation, a Pennsylvania corporation (“GPEC”), pursuant to a Share Exchange Agreement (the “Share Exchange Transaction”). Immediately following the closing of the Share Exchange Transaction, the Company owned 100% of equity interests of GPEC and GPEC became a wholly-owned subsidiary of the Company. On November 25, 2013, the Company changed its name from “Universal Technology Systems, Corp.” to “NanoFlex Power Corporation” and its trading symbol was changed to “OPVS” on December 26, 2013. GPEC was founded and incorporated on February 7, 1994 and is engaged in the research, development, and commercialization of advanced configuration solar technologies. The Company’s sponsored research programs at the University of Southern California (“USC”), the University of Michigan (“Michigan”), and Princeton University have resulted in an extensive portfolio of issued and pending patents worldwide. Pursuant to its sponsored research agreements, NanoFlex has obtained the exclusive worldwide license and right to sublicense any and all intellectual property resulting from the Company’s sponsored research programs. While each patent is issued in the name of the respective university that developed the subject technology, NanoFlex has exclusive commercial license rights to all of the patents and their attendant technologies and the patents are referred to herein as being NanoFlex’s patents. These patented and patent-pending technologies fall into two general categories. Gallium Arsenide (GaAs) solar technologies involve fabrication processes and device architectures to substantially reduce the cost of ultra-high efficiency GaAs thin films. Organic Photovoltaics (OPV) technologies involve the materials, architectures, and fabrication processes for ultra-thin film semi-transparent solar cells. The technologies are targeted at, but not limited to, certain broad applications that require high power conversion efficiency, flexibility, and light weight. These applications include, but are not limited to: (a) portable power mats and sheets for military and field use, (b) building applied photovoltaics (“BAPV”), (c) building integrated photovoltaics (“BIPV”), (d) space vehicles and unmanned aerial vehicles (“UAVs”), (e) semi-transparent solar power generating glazing or windows, and (f) ultra-thin solar films for consumer applications such as mobile devices or automobiles. Laboratory feasibility prototypes have been developed by the engineering team at University of Michigan that successfully demonstrate key building block principles for these technology application areas and the Company is working with industry partners to commercialize its technologies. Basis of Presentation The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. On an ongoing basis, we evaluate our estimates, including those related to revenue recognition, income taxes, inventory, long lived assets and contingencies. These estimates are based on management’s best knowledge of current events, historical experience, actions that we may undertake in the future and on various other assumptions that are believed to be reasonable under the circumstances. As a result, actual results could differ materially from these estimates and assumptions. Revision of Previously-Issued Financial Statements 2015 During the three months ended June 30, 2016, the Company identified errors in its financial statements for the third and fourth quarters of the fiscal year ended December 31, 2015, and first quarter of the fiscal year ended March 31, 2016, as included in the Company’s 10-Q for the periods ended September 30, 2015 and March 31, 2016, and its 2015 annual report on Form 10-K, related to the accounting for conversion option derivative liabilities. Specifically, the Company accounted for all of its convertible debt instruments assuming that each contained an embedded conversion feature that met the criteria for bifurcation when, in fact, several of the outstanding notes contained embedded conversion features that did not require bifurcation. The Company has made adjustments in each period related to this. The Company assessed the effect of the above errors in the aggregate on prior periods’ financial statements in accordance with the SEC’s Staff Accounting Bulletins No. 99 and 108 and, based on an analysis of quantitative and qualitative factors, determined that the errors were not material to any of the Company’s prior interim and annual financial statements. The Company determined that the correction of the cumulative amounts of the errors would be material to its consolidated financial statements for the year ended December 31, 2016. Therefore, the Company revised its previously-issued financial statements as of December 31, 2015 and for the year then ended. The consolidated balance sheet as of December 31, 2015 and the consolidated statement of operations for the year ended December 31, 2015 included herein are revised as described below for those adjustments. All financial information contained in the accompanying notes to these financial statements has been revised to reflect the correction of these errors. The following tables present the effect of the aforementioned revisions on the Company’s consolidated balance sheet for the year ended December 31, 2015: As of December 31, 2015 As Reported Revision As Revised Conversion option derivative liability $ 8,145,160 $ (2,733,973 ) $ 5,411,187 Convertible debt, net of unamortized discounts 1,051,545 72,273 1,123,818 Total current liabilities 28,168,610 (2,661,700 ) 25,506,910 Total liabilities 28,168,610 (2,661,700 ) 25,506,910 Accumulated deficit (204,989,355 ) 3,484,877 (201,504,478 ) Additional paid in capital 176,932,064 (823,177 ) 176,108,887 Total stockholders' deficit (28,052,143 ) 2,661,700 (25,390,443 ) The following tables present the effect of the aforementioned revisions on the Company’s consolidated statement of operations for the year ended December 31, 2015: Year Ended December 31, 2015 As Reported Revision As Revised Loss on change in fair value of derivative $ (13,901,957 ) $ 3,708,739 $ (10,193,218 ) Interest expense (1,685,160 ) (223,862 ) (1,909,022 ) Total other expense (15,737,117 ) 3,484,877 (12,252,240 ) Net loss (26,801,396 ) 3,484,877 (23,316,519 ) Net loss per share (basic and diluted) (0.56 ) (0.07 ) (0.49 ) These revisions to the consolidated statements of cash flows for the year ended December 31, 2015 did not result in any changes to the amounts previously reported for net cash provided by (used in) operating, investing and financing activities.

Going Concern

Going Concern	12 Months Ended
	Dec. 31, 2016
Going Concern [Abstract]
Going Concern	Note 2: Going Concern The Company has only generated limited revenues to date. The Company has a working capital deficit of $19,246,667 and an accumulated deficit of $208,565,839 as of December 31, 2016. The ability of the Company to continue as a going concern is dependent on raising capital to fund ongoing operations and carry out its business plan and ultimately to attain profitable operations. Accordingly, these factors raise substantial doubt as to the Company’s ability to continue as a going concern. The financial statements do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts of and classification of liabilities that might be necessary in the event the Company cannot continue in existence. To date, the Company has funded its initial operations primarily by way of the sale of equity securities, convertible note financing, short term financing from private parties, and advances from related parties. The Company currently needs to raise additional capital in order to maintain its sponsored research agreements, its patent portfolio, research and development activities and efforts to commercialize its technologies, as well as to make payments on existing liabilities. The Company is continuing to raise capital, as it did during the year ended December 31, 2016, in order to continue the Company’s business operations. The Company currently requires approximately $6 million to $8 million to continue its operations over the next twelve months. There can be no assurance that the Company will be able to continue to raise sufficient capital or that it will be available on terms that are acceptable to the Company and its shareholders. The Company’s management is also actively seeking strategic partners for licensing and/or joint development of Company technologies as well as prioritizing our current IP portfolio to identify opportunities for cost reduction. The Company’s management is also seeking to reduce costs. There can be no assurance that the Company’s management will be successful in its planned efforts, and a failure to do so may lead to the Company being unable to continue its operations.

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2016
Summary of Significant Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 3: Summary of Significant Accounting Policies Cash and Cash Equivalents For purposes of the statement of cash flows, the Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents. Principles of Consolidation The consolidated financial statements include the accounts of the Company and its controlled subsidiaries. Intercompany transactions and balances are eliminated at consolidation. Equity investments in which we exercise significant influence, but do not control and are not the primary beneficiary, are accounted for using the equity method of accounting. Investments in which we do not exercise significant influence over the investee are accounted for using the cost method of accounting. Accounts Receivable Accounts receivable are carried at the original invoiced amount less an allowance for doubtful accounts based on the probability of future collection. Management reviews accounts receivable on a periodic basis to determine if any receivables will potentially be uncollectible. The Company reserves for receivables that are determined to be uncollectible, if any, in its allowance for doubtful accounts. After the Company has exhausted all collection efforts, the outstanding receivable is written off against the allowance. Property and Equipment Property and equipment are stated at cost. Depreciation of property and equipment is provided using the straight-line method for financial reporting purposes at rates based on the estimated useful lives of the assets. Estimated useful lives range from three to eight years. Impairment of Long-lived Assets The Company reviews the carrying value of its long-lived assets annually or whenever events or changes in circumstances indicate that the historical-cost carrying value of an asset may no longer be appropriate. The Company assesses recoverability of the asset by comparing the undiscounted future net cash flows expected to result from the asset to its carrying value. If the carrying value exceeds the undiscounted future net cash flows of the asset, an impairment loss is measured and recognized. An impairment loss is measured as the difference between the net book value and the fair value of the long-lived asset. Fair value is estimated based upon either discounted cash flow analysis or estimated salvage value. Stock-Based Compensation We account for stock based compensation in accordance with FASB ASC 718 which requires companies to measure the cost of employee services received in exchange for an award of an equity instrument based on the grant-date fair value of the award. Stock-based compensation expense is recognized on a straight-line basis over the requisite service period. We account for non-employee share-based awards in accordance with FASB ASC 505-50 under which the awards are valued at the earlier of a commitment date or upon completion of the services, based on the fair value of the equity instruments, and are recognized as expense over the service period. Use of Estimates The preparation of these financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that may affect certain reported amounts and disclosures in the financial statements and accompanying notes. The significant estimates relate useful lives of software licenses, valuation of beneficial conversion feature on convertible debts, valuation of warrants and stock options, and valuation allowance for deferred income taxes. Actual results could differ from those estimates. Concentration of Credit Risk and Significant Customers Cash is maintained in bank accounts which, at times, may exceed federally insured limits. The Company has not experienced any losses in such accounts and does not believe it is exposed to any significant credit risk on cash. The Company’s revenue and accounts receivable are currently earned primarily from one customer. Revenue Recognition The Company recognizes revenue from its services when it is probable that the economic benefits associated with the transactions will flow to the Company and the amount of revenue can be measured reliably. This is normally demonstrated when: (i) persuasive evidence of an arrangement exists; (ii) the fee is fixed or determinable; (iii) performance of service has been delivered; and (iv) collection is reasonably assured. Revenue from our joint development agreements are recognized as services are provided and are limited to the total dollar amount specified in the agreement. R&D engineering services, through joint development agreements are a core component of NanoFlex’s operations and business model, since they are a necessary prerequisite to obtaining IP licensing agreements with customers. As such, R&D engineering services are expected to be a sustained revenue stream for NanoFlex as it works with additional customers and the services constitute a portion of the Company's ongoing central operations. The terms of the joint development agreement require the counterparty to pay Nanoflex up to $120,000 for the Company’s engineering related expenses upon successful completion of a proof of concept. Terms of the invoices are net 30 days. As of December 31, 2016, the Company has entered into one joint development agreement. Research and Development Research and development costs are expensed in the period they are incurred in accordance with ASC 730, Research and Development unless they meet specific criteria related to technical, market and financial feasibility, as determined by management, including but not limited to the establishment of a clearly defined future market for the product, and the availability of adequate resources to complete the project. If all criteria are met, the costs are deferred and amortized over the expected useful life, or written off if a product is abandoned. At December 31, 2016 and 2015, the Company had no deferred development costs. Fair Value of Financial Instruments The carrying value of short-term financial instruments, including cash, accounts receivable, accounts payable and accrued expenses, and short-term borrowings approximate fair value due to the relatively short period to maturity for these instruments. The long-term borrowings approximate fair value since the related rates of interest approximates current market rates. Income Taxes Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. These assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which the temporary differences are expected to reverse. We have net operating loss carry-forwards available to reduce future taxable income. Future tax benefits for these net operating loss carry-forwards are recognized to the extent that realization of these benefits is considered more likely than not. To the extent that we will not realize a future tax benefit, a valuation allowance is established. We recognize and measure benefits for uncertain tax positions using a two-step approach. The first step is to evaluate the tax position taken or expected to be taken in a tax return by determining if the weight of available evidence indicates that is it more likely than not that the tax positions will be sustained upon audit, including resolution of any related appeals or litigation processes. For tax positions that are more likely than not to be sustained upon audit, the second step is to measure the tax benefit as the largest amount that is more than 50% likely to be realized upon settlement. Our practice is to recognize interest and/or penalties related to income tax matters in income tax expense. Significant judgment is required to evaluate uncertain tax positions. Evaluations are based upon a number of factors, including changes in facts or circumstances, changes in tax law, correspondence with tax authorities during the course of tax audits and effective settlement of audit issues. Changes in the recognition or measurement of uncertain tax positions could result in material increases or decreases in income tax expense in the period in which the change is made, which could have a material impact on our effective tax position.

Fair Value of Financial Instrum

Fair Value of Financial Instruments	12 Months Ended
	Dec. 31, 2016
Fair Value of Financial Instruments [Abstract]
Fair Value of Financial Instruments	Note 4: Fair Value of Financial Instruments ASC 820 Fair Value Measurements and Disclosures (“ASC 820”), defines fair value, establishes a framework for measuring fair value and enhances disclosures about fair value measurements. It defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value: Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities that are not active; and model-driven valuations whose inputs are observable or whose significant value drivers are observable. Valuations may be obtained from, or corroborated by, third-party pricing services. Level 3: Unobservable inputs to measure fair value of assets and liabilities for which there is little, if any market activity at the measurement date, using reasonable inputs and assumptions based upon the best information at the time, to the extent that inputs are available without undue cost and effort. As of December 31, 2016 the significant inputs to the Company’s derivative liability calculation were Level 3 inputs. The following schedule summarizes the valuation of financial instruments at fair value in the balance sheets as of December 31, 2016 and December 31, 2015: Fair Value Measurements as of Level 1 Level 2 Level 3 Assets None $ $ $ Total assets - - - Liabilities Warrant derivative liability - - 8,828,405 Conversion option derivative liability - - 3,156,736 Total liabilities - - 11,985,141 Fair Value Measurements as of Level 1 Level 2 Level 3 Assets None $ $ $ Total assets - - - Liabilities Warrant derivative liability - - 12,796,146 Conversion option derivative liability - - 5,411,187 Total liabilities - - 18,207,333 The following table sets forth a reconciliation of changes in the fair value of financial assets and liabilities classified as Level 3 in the fair value hierarchy: Significant Unobservable Inputs (Level 3) Year Ended December 31, 2016 2015 Beginning balance $ 18,207,333 $ 847,791 Change in fair value (7,326,535 ) 10,193,218 Additions reclassified from equity 559,900 5,819,389 Additions recognized as debt discounts - - Additions recognized as compensation expense 544,443 1,346,935 Ending balance $ 11,985,141 $ 18,207,333

Recent Accounting Pronouncement

Recent Accounting Pronouncements	12 Months Ended
	Dec. 31, 2016
Recent Accounting Pronouncements [Abstract]
Recent Accounting Pronouncements	Note 5: Recent Accounting Pronouncements In September 2015, the FASB issued ASU No. 2015-16, “Simplifying the Accounting for Measurement-Period Adjustments”. In November 2015, the FASB issued ASU 2015-17, “Income Taxes (Topic 470): Balance Sheet Classification of Deferred Taxes”. In January 2016, the FASB issued ASU No. 2016-01, “Financial Instruments – Overall (Subtopic 825-10), Recognition and Measurement of Financial Assets and Financial Liabilities”, In February, 2016, the FASB issued ASU No. 2016-02 ,” Leases” (Topic 842) In March 2016, the FASB issued ASU 2016-09, “ Compensation - Stock Compensation: Improvements to Employee Share-Based Payment Accounting In April 2016, the FASB issued ASU No. 2016-10, “ Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing In May 2016, the FASB issued ASU No. 2016-12, “ Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients In August 2016, the FASB issued ASU No. 2016-15, “Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments”. In November 2016, the FASB issued ASU No. 2016-18, “Statement of Cash Flows (Topic 230): Restricted Cash”

Debt

Debt	12 Months Ended
	Dec. 31, 2016
Debt [Abstract]
Debt	Note 6: Debt Notes Payable The Company has a note payable of $100,000 due to its former Chief Executive Officer and President. The note is due on demand and bears an interest rate at the minimum applicable rate for loans of similar duration, which was 0.5% as of December 31, 2016. During the year ended December 31, 2015, the Company issued a promissory note of $50,000. The term of the note expires 120 days from the effective date. 100,000 cashless warrants for the Company’s common shares were issued with the debt at a strike price of $0.50/share in lieu of cash interest. The relative fair value of the warrants of $45,243 was recognized as a debt discount which is being amortized on a straight-line basis over the term of the note. The Company recognized interest expense of $45,243 associated with the amortization of debt discount for the year ended December 31, 2015. On May 12, 2016, this note was forgiven in exchange for a new convertible note that bears interest of 8% per annum, a maturity date of one year and is convertible into units at $0.50 per unit, with each unit consisting of a share of common stock and a warrant with a five year life from the date of conversion and an exercise price of $0.50 per share, subject to certain anti-dilution provisions. This modification qualifies as an extinguishment of debt. The fair value of 50,000 warrants issued in connection with the modification which have a term of 5 years and are exercisable at $0.50 per share resulted in a loss on extinguishment of debt of $44,044. The modified note also gave rise to a beneficial conversion feature of $54,487 which is recognized as additional paid in capital and a corresponding debt discount. All debt discounts are being recognized on a straight-line basis over the term of the note. The note also contains an additional warrant expense of $12,415 associated with the warrants that are to be issued upon conversion, which is to be recognized only upon conversion. During the year ended December 31, 2016, the Company issued a promissory note of $300,000. The term of the note expires one year from the effective date and has an interest rate of 10%. 600,000 cashless warrants for the Company’s common shares were issued with the debt at a strike price of $0.50/share in lieu of cash interest. The relative fair value of the warrants of $235,188 was recognized as a debt discount which is being amortized on a straight-line basis over the term of the note. The Company recognized interest expense of $78,396 associated with the amortization of debt discount and the remaining unamortized discount is $156,792 as of December 31, 2016. As of December 31, 2016 and December 31, 2015, the aggregate outstanding balance of non-convertible notes payable was $400,000 and $150,000, respectively. Notes Payable – Related Party On February 26, 2014, the Company borrowed $150,000 under a short term note agreement with a related party, the Chief Executive Officer’s son. Under the terms of this agreement, the note was to be repaid within 6 months of funding. In November 2014, the note agreement was amended to extend the due date to February 26, 2015, and in April of 2015, the note agreement was amended to extend the maturity date to February 26, 2016 and set a 4% simple interest rate on the note. This note was paid in full in January of 2016 along with $509 of accrued interest. In 2015, the Company issued promissory notes to a majority shareholder in aggregate of $625,000 (“Notes #1 to #4”). The notes have a term ranging from 120 – 150 days from the effective date. 1,250,000 cashless warrants for the Company’s common shares were issued with the debt at a strike price of $0.50/share in lieu of cash interest. On January 6, 2016, the Company issued an additional promissory note to the same majority shareholder in the amount of $1,375,000 in exchange for a loan in that amount (“Note #5). The Company issued 2,750,000 warrants in connection with this Note #5, for the Company’s common stock at an exercise price of $0.50 per share. The total relative fair value of the warrants of $996,178 was recognized as a debt discount which is being amortized on a straight-line basis over the term of the notes. Notes #1 to #4 and Note #5 shall be collectively referred to herein as the “$2M Notes.” Total amortization of discount during 2016 is $173,948. On January 22, 2016, the Company entered into a Note Conversion Agreement (the “Conversion Agreement”) with the holder of the $2 million notes. Pursuant to the Conversion Agreement, the investor converted the $2 million notes, which totaled $2,000,000, into an investment of $2,000,000 into the Company’s private placement of convertible notes and warrants. This extinguishment of the $2 million notes resulted in a loss on extinguishment of debt of $3,163,303 which included an unamortized discount of $926,382 and $2,236,921 representing the fair value of 2,000,000 warrants issued in connection with the Note Conversion Agreement. Additionally, the Company recognized a beneficial conversion feature of $995,171 in accordance with the provisions of ASC 470-20 “ Debt – Debt with Conversion and Other Options” On January 25, 2016, the investor converted the convertible note and accrued interest into 4,320,000 shares of the Company’s common stock and a warrant to purchase 4,320,000 shares of the Company’s common stock with a ten year term and an exercise price of $0.50 per share. Of the 4,320,000 shares of common stock, 320,000 shares represent interest paid on the convertible note pursuant to the terms of the conversion agreement in the amount of $160,000. Upon conversion, the Company accelerated the recognition of all remaining debt discount and also recognized an additional interest expense of $1,004,829 associated with the warrants that were issued upon conversion. This contingent beneficial conversion feature was immediately recognized as interest expense with an offset to additional paid-in-capital. On November 21, 2016, the Company borrowed $300,000 under a short term note agreement with a majority shareholder. Under the terms of this agreement, the note is to be repaid within 60 days of funding along with $15,000 paid at the maturity of the note in lieu of interest. On December 27, 2016, the Company borrowed $200,000 under a short term note agreement with a majority shareholder. Under the terms of this agreement, the note is to be repaid within 60 days of funding along with $10,000 paid at the maturity of the note in lieu of interest. As of December 31, 2016 and December 31, 2015, the aggregate outstanding balance of notes payable to related parties was $500,000 and $670,848, respectively, net of unamortized discounts of $0 and $104,152, respectively. Advances – Related Party During the year ended December 31, 2015, the Company received advances from its Chief Executive Officer totaling $212,350, and repaid advances totaling $530,500. Such advances are payable upon demand and do not accrue interest. The Company paid interest of $7,989 during the year ended December 31, 2015. During the year ended December 31, 2016, the Company received advances from its Chief Executive Officer totaling $730,000 and repaid advances totaling $330,000. Such advances do not accrue interest and are payable upon demand. The Company paid interest of $16,678 during the year ended December 31, 2016. As of December 31, 2016 and 2015, the aggregate outstanding balance of advances to related parties was $510,000 and $110,000, respectively. Convertible Notes Payable In July 2014, the Company borrowed $500,000 under two short term note agreements of $250,000 each. Under the terms of each agreement, the principal balance of $250,000 and interest of $16,500 was due to be repaid within 4 months of the date of the note. These agreements were amended on February 23, 2015 to extend the due date to July 21, 2015 and increase the interest amount to $25,000. The Company analyzed the amendment of the note under ASC 470 and concluded that the amendment did not qualify as a substantial modification. The agreements allow the holder to convert all or a portion of the principal and accrued interest into equity as a conversion rate of $1.25. On June 30, 2015, these notes and accrued interest of $50,000 were exchanged for two new convertible note agreements for $350,000 each and the issuance of 700,000 warrants with a five year life and an exercise price of $0.50 per share. The convertible note each have a principal amount of $350,000, interest of 8% per annum, a maturity date of June 30, 2016 and are convertible into 700,000 units, with each unit consisting of a share of common stock and a warrant with a five year life from the date of conversion and an exercise price of $0.50 per share, subject to certain anti-dilution provisions. The Company analyzed the amendment of the note under ASC 470 and concluded that the exchange gave rise to a debt extinguishment, which resulted in a loss on extinguishment of $150,000. The Company allocated the new proceeds to the warrants and the convertible debt based on their relative fair values, then, computed the effective conversion price of each instrument, noting that the convertible debt gave rise to a beneficial conversion feature in accordance with the provisions of ASC 470-20 “ Debt - Debt with Conversion and Other Options.” On December 19, 2014, the Company received aggregate proceeds of $300,000 in exchange for a convertible note and the issuance of 200,000 warrants with a five year life and an exercise price of $2.50 per share. The convertible note has a principal amount of $300,000, interest of 8% per annum, a maturity date of December 19, 2015, and is convertible into 300,000 units, with each unit consisting of a share of common stock and a warrant with a five year life from the date of conversion and an exercise price of $1 per share, subject to certain anti-dilution provisions. The Company allocated the proceeds to the warrants and the convertible debt based on their relative fair values, then computed the effective conversion price of each instrument, noting that the convertible debt gave rise to a beneficial conversion feature in accordance with the provisions of ASC 470-20 “ Debt - Debt with Conversion and Other Options.” In March 2015, the Company received aggregate proceeds of $700,000 in exchange for convertible notes and the issuance of 466,667 warrants with a five year life and an exercise price of $2.50 per share. The convertible notes have a principal amount of $700,000, interest of 8% per annum, a maturity date of March 2016 and are convertible into 700,000 units, with each unit consisting of a share of common stock and a warrant with a five year life from the date of conversion and an exercise price of $1 per share, subject to certain anti-dilution provisions. The Company allocated the proceeds to the warrants and the convertible debt based on their relative fair values, then, computed the effective conversion price of each instrument, noting that the convertible debt gave rise to a beneficial conversion feature in accordance with the provisions of ASC 470-20 “ Debt - Debt with Conversion and Other Options.” In June 2015, the Company received aggregate proceeds of $530,000 in exchange for convertible notes and the issuance of 530,000 warrants with a five year life and an exercise price of $0.50 per share. The convertible notes have a principal amount of $530,000, interest of 8% per annum, a maturity date of June 2016 and are convertible into 1,060,000 units, with each unit consisting of a share of common stock and a warrant with a five year life from the date of conversion and an exercise price of $.50 per share, subject to certain anti-dilution provisions. The Company allocated the proceeds to the warrants and the convertible debt based on their relative fair values, then, computed the effective conversion price of each instrument, noting that the convertible debt gave rise to a beneficial conversion feature in accordance with the provisions of ASC 470-20 “ Debt - Debt with Conversion and Other Options.” From July 8, 2015 to December 31, 2015, the Company received aggregate proceeds of $914,049 in exchange for convertible notes and the issuance of 914,049 warrants with a five year life and an exercise price of $0.50 per share. The convertible notes have an aggregate principal amount of $914,049, interest of 8% per annum, a maturity date of one year and are convertible into 1,728,098 units, with each unit consisting of a share of common stock and a warrant with a five year life from the date of conversion and an exercise price of $.50 per share, subject to certain anti-dilution provisions. The aggregate relative fair value of the 914,049 warrants issued with the debt was determined to be $594,498 and was recognized as a discount to the debt. These notes also gave rise to a beneficial conversion feature of $172,869 which was recognized as additional paid-in-capital and a corresponding debt discount. All debt discounts are being recognized on a straight-line basis over the term of the note. The note also contains an additional warrant expense of $146,682 associated with the warrants that are to be issued upon conversion, which is to be recognized only upon conversion. During the year ended December 31, 2015, certain notes with principal of $1,634,928 and accrued interest of $26,687 were converted pursuant to the terms of the notes into 3,323,230 shares of the Company’s common stock and 3,323,230 warrants to purchase common stock. Upon conversion, the Company accelerated the recognition of all remaining debt discount and also recognized additional interest expense of $494,730 associated with the warrants that were issued upon conversion. This additional warrant expense was immediately recognized as interest expense with an offset to additional paid-in-capital. In addition to the $2,000,000 convertible note described above in the Notes Payable-Related Party section, on March 7, 2016, the Company received proceeds of $80,000 in exchange for a convertible note and the issuance of 80,000 warrants with a five year life and an exercise price of $0.50 per share. The convertible note has a principal amount of $80,000, interest of 8% per annum, a maturity date of one year and is convertible into 160,000 units, with each unit consisting of a share of common stock and a warrant with a five year life from the date of conversion and an exercise price of $0.50 per share, subject to certain anti-dilution provisions. The relative fair value of the 80,000 warrants issued with the debt was determined to be $38,205 and was recognized as a discount to the debt. This note also gave rise to a beneficial conversion feature of $20,898 which is recognized as additional-paid-in capital and a corresponding debt discount. All debt discounts are being recognized on a straight-line basis over the term of the note. The note also contains an additional warrant expense of $20,897 associated with the warrants that are to be issued upon conversion, which is to be recognized only upon conversion. From April 18, 2016 through June 30, 2016, the Company received additional aggregate proceeds of $375,000 in exchange for eight convertible notes and the issuance of 375,000 warrants with a five year life and exercise price of $0.50 per share. The convertible notes have an aggregate principal amount of $375,000, interest of 8% per annum, a maturity date of one year and are convertible into an aggregate of 750,000 units, with each unit consisting of a share of common stock and a warrant with a five year life from the date of conversion and an exercise price of $0.50 per share, subject to certain anti-dilution provisions. The aggregate relative fair value of the 375,000 warrants issued with the debt was determined to be $158,423 and was recognized as a discount to the debt. These notes also gave rise to a beneficial conversion feature of $108,291 which is recognized as additional paid in capital and a corresponding debt discount. All debt discounts are being recognized on a straight-line basis over the term of the note. The note also contains an additional warrant expense of $108,286 associated with the warrants that are to be issued upon conversion, which is to be recognized only upon conversion. On July 13, 2016, the Company entered into a note purchase agreement with an investor pursuant to which an investor purchased a promissory note from the Company and received 500,000 warrants with a seven year life and exercise price of $0.50 per share in exchange for $500,000. The promissory note had a clause that automatically modified it 30 days after issuance (on August 12, 2016) into a convertible note. The convertible note has a principal amount of $500,000, includes the issuance of 500,000 additional warrants, interest of 8% per annum, a maturity date of one year and is convertible into 1,000,000 units, with each unit consisting of a share of common stock and a warrant with a five year life from the date of conversion and an exercise price of $0.50 per share, subject to certain anti-dilution provisions. The relative fair value of the 500,000 warrants issued on July 13, 2016 was $161,010. The relative fair value of the 500,000 warrants issued on August 12, 2016 was $117,377. The total of $278,386 was recognized as a discount to the debt. This note also gave rise to a beneficial conversion feature of $116,754 which is recognized as additional paid in capital and a corresponding debt discount. All debt discounts are being recognized on a straight-line basis over the term of the note. The note also contains an additional warrant expense of $104,860 associated with the warrants that are to be issued upon conversion, which is to be recognized only upon conversion. From July 6, 2016 through September 30, 2016, the Company received additional aggregate proceeds of $244,500 in exchange for 12 convertible notes and the issuance of 244,500 warrants with a five year life and exercise price of $0.50 per share. The convertible notes have an aggregate principal amount of $244,500, interest of 8% per annum, a maturity date of one year and are convertible into an aggregate of 489,000 units, with each unit consisting of a share of common stock and a warrant with a five year life from the date of conversion and an exercise price of $0.50 per share, subject to certain anti-dilution provisions. The aggregate relative fair value of the 244,500 warrants issued with the debt was determined to be $102,835 and was recognized as a discount to the debt. These notes also gave rise to a beneficial conversion feature of $73,653 which is recognized as additional paid in capital and a corresponding debt discount. All debt discounts are being recognized on a straight-line basis over the term of the note. The note also contains an additional warrant expense of $68,012 associated with the warrants that are to be issued upon conversion, which is to be recognized only upon conversion. On October 7, 2016, the Company entered into a note purchase agreement with an investor pursuant to which an investor purchased a promissory note from the Company and received 200,000 warrants with a five year life and exercise price of $0.50 per share in exchange for $100,000. The promissory note had a clause that automatically modified it 30 days after issuance (on November 7, 2016) into a convertible note. The convertible note has a principal amount of $100,000, includes the issuance of 100,000 additional warrants, interest of 8% per annum, a maturity date of one year and is convertible into 200,000 units, with each unit consisting of a share of common stock and a warrant with a five year life from the date of conversion and an exercise price of $0.50 per share, subject to certain anti-dilution provisions. The relative fair value of the 200,000 warrants issued on October 7, 2016 was $52,848. The relative fair value of the 100,000 warrants issued on November 7, 2016 was $21,526. The total of $74,374 was recognized as a discount to the debt. This note also gave rise to a beneficial conversion feature of $13,209 which is recognized as additional paid in capital and a corresponding debt discount. All debt discounts are being recognized on a straight-line basis over the term of the note. The note also contains an additional warrant expense of $12,416 associated with the warrants that are to be issued upon conversion, which is to be recognized only upon conversion. From October 19, 2016 through December 31, 2016, the Company received additional aggregate proceeds of $158,500 in exchange for six convertible notes and the issuance of 158,500 warrants with a five year life and exercise price of $0.50 per share. The convertible notes have an aggregate principal amount of $158,500, interest of 8% per annum, a maturity date of one year and are convertible into an aggregate of 317,000 units, with each unit consisting of a share of common stock and a warrant with a five year life from the date of conversion and an exercise price of $0.50 per share, subject to certain anti-dilution provisions. The aggregate relative fair value of the 158,500 warrants issued with the debt was determined to be $64,927 and was recognized as a discount to the debt. These notes also gave rise to a beneficial conversion feature of $48,508 which is recognized as additional paid in capital and a corresponding debt discount. All debt discounts are being recognized on a straight-line basis over the term of the note. The note also contains an additional warrant expense of $45,064 associated with the warrants that are to be issued upon conversion, which is to be recognized only upon conversion. During the year ended December 31, 2016, the full principal balances of certain notes totaling $1,233,621 with accrued interest of $89,480 were converted pursuant to the terms of the notes into 2,646,199 shares of the Company’s common stock and 2,646,199 warrants to purchase common stock. Upon conversion, the Company accelerated the recognition of all remaining debt discount and also recognized additional interest expense of $1,297,324 associated with the warrants that were issued upon conversion. This additional warrant expense was immediately recognized as interest expense with an offset to additional paid-in-capital. Aggregate amortization of the discounts on the convertible notes for the year ended December 31, 2016 and 2015 was $2,196,621 and $933,103, respectively. As of December 31, 2016 and 2015, the aggregate outstanding balance of convertible notes payable was $1,440,206 and $1,123,818, respectively, net of unamortized discounts of $343,294 and $457,576. Derivative Liabilities - Convertible Notes On July 13, 2015, the Company’s common stock began trading, although such trading was limited. As a result, the embedded conversion and anti-dilution features of the Company’s convertible debt agreements were determined to meet the definition of a derivative per ASC 815, Derivatives and Hedging. This resulted in the recording of a derivative liability on July 13, 2015, which was a reclassification out of additional paid-in capital of $5,743,021 representing the fair value of the conversion options in the outstanding derivative notes as of July 13, 2015. The fair value of the convertible feature was determined based on a fair value of $3,132,526 and $2,610,495 assigned to the warrant and conversion options, respectively. As of December 31, 2015, the fair value of the outstanding convertible note derivatives was determined to be $5,411,187 and recognized a gain of $331,834. As of December 31, 2016, the fair value of the outstanding convertible note derivatives was determined to be $3,156,736 and recognized a gain of $2,254,451. There were no new convertible note derivatives that arose during the year ended December 31, 2016. The valuation of the derivative liabilities attached to the convertible debt was arrived at through the use of Black-Scholes Option Pricing Model and the following assumptions: Year Ended December 31, 2016 2015 Volatility 135.41% - 232.51% 135.41% - 197.50% Risk-free interest rate 0.45% - 1.47% 0.16% - 1.54% Expected term 1 - 4 years 0.25 - 4.25 years Accounts Payable - Related Party As of December 31, 2016 and 2015, there is $2,470 and $62,469, respectively, due to a related party, the Company’s Chief Financial Officer, which is non interest bearing due on demand.

Equity

Equity	12 Months Ended
	Dec. 31, 2016
Equity [Abstract]
Equity	Note 7. Equity Common Stock During the year ended December 31, 2015, the Company sold an aggregate of 86,000 units, at $1.00 per unit for aggregate proceeds of $86,000, respectively. Each unit consisted of one common share and one warrant. Each warrant is exercisable for a period of five years from the date of issuance, at $1.00 per share. During the year ended December 31, 2015, the Company issued an aggregate of 3,323,230 shares of its common stock related to the conversion of $1,634,928 of principal and $26,687 accrued interest expense on convertible notes. Of the common shares issued, 53,374 shares related to the payment of interest. During the year ended December 31, 2015, the Company issued an aggregate of 1,828,437 shares of its common stock related to the exercise of 1,828,437 warrants and received cash proceeds of $914,220. Pursuant to an anti-dilution provision in the subscription agreements executed by the $1.00 PIPE II and $1.25 PIPE II investors which provides for the issuance of a certain number of additional shares based on a formula in the subscription agreements, to these holders in the event that the company within 36 months of the completion of all PIPE II sales issues any common stock or securities convertible into or exercisable for shares of common stock at a lower price than the purchase price paid by the PIPE II investors. As a result of the Company's offering of such securities at a price lower than the price paid by the PIPE II investors, the Company issued 1,554,500 shares of common stock to the PIPE II investors in the year ended December 31, 2015. On October 19, 2015, 75,288 shares of the Company’s common stock were cancelled in exchange for convertible notes of $37,644 and the issuance of 37,644 warrants with a five year life and an exercise price of $0.50 per share, as well as 75,288 warrants with a five year life and an exercise price of $2.50 per share. The convertible notes have a principal amount of $37,644, interest of 8% per annum, a one year term, and are convertible into 37,644 units, with each unit consisting of a share of common stock and a warrant with a five year life from the date of conversion and an exercise price of $0.50 per share, subject to certain anti-dilution provisions. The agreement was subsequently amended to include an additional 75,288 units with each unit consisting of a share of common stock with a five year life from the date of grant and an exercise price of $2.50 per share, subject to certain anti-dilution provisions. On November 6, 2015, the Company issued 350,000 shares of its common stock in exchange for services pursuant to a consulting agreement. The shares were valued at $350,000 which was based on the stock price on the grant date. On December 9, 2015, the Company issued units which consisted of 100,000 shares and warrants to purchase 250,000 shares of its common stock exercisable at $0.50 per share and a term of 10 years in exchange for total proceeds of $50,000. The Company allocated the gross proceeds of $50,000 between common stock and warrants based on their relative fair value, estimated on the date of grant, valued common stock and the warrants at $14,532 and $35,468, respectively. During the year ended December 31, 2016, the Company issued 245,878 common shares and warrants to purchase 426,741 common shares of the Company’s common stock in exchange for proceeds of $67,536. The Company determined a fair value for the shares and warrants to be $617,175. The cash was received prior to December 31, 2015 and was recorded as an accrued liability at December 31, 2015. This transaction resulted in a loss on extinguishment of liability of $549,639. During the year ended December 31, 2016, the Company issued 1,434,076 common shares and warrants to purchase 4,546,252 common shares of the Company’s common stock in exchange for proceeds of $663,922 and interest expense of $6,023. During the year ended December 31, 2016, the Company issued 144,411 common shares on exercise of warrant at price of $0.50 per share for a total of $72,205. During the year ended December 31, 2016, the Company issued an aggregate of 2,646,199 shares of its common stock related to the conversion of $1,233,621 of principal and $89,480 accrued interest expense on convertible notes. Stock Options On April 28, 2013, the Board of Directors adopted the 2013 Stock Option Plan. Under the Plan, the Company may grant incentive stock options to employees and non-qualified stock options to employees, non-employee directors and/or consultants. The Plan provides for the granting of a maximum of 2,000,000 options to purchase common stock. The ISO exercise price per share may not be less than the fair market value of a share on the date the option is granted. The maximum term of the options may not exceed ten years. On December 23, 2015, 50,000 stock options were granted to an employee of the Company. The options vest on a monthly basis of 1,000 shares per month over a 50 month period. The options expire in 2025. On October 3, 2016, 50,000 stock options were granted to an employee of the Company. The options vest on a monthly basis of 1,000 shares per month over a 50 month period. The options expire in 2026. These options were valued based on the grant date fair value of the instruments, net of estimated forfeitures, using a Black-Scholes option pricing model with the following assumptions: Years Ended December 31, 2016 2015 Volatility 144.36 % 122.87 % Risk-free interest rate 1.32 % 1.91 % Expected term 6.06 years 6.06 years The volatility used was based on historical volatility of similar sized companies due to lack of historical data of the Company’s stock price. The risk free interest rate was determined based on treasury securities with maturities equal to the expected term of the underlying award. The expected term was determined based on the simplified method outlined in Staff Accounting Bulletin No. 110. Stock option awards are expensed on a straight-line basis over the requisite service period. During the years ended December 31, 2016 and 2015, the Company recognized expense of $19,157 and $364, respectively, associated with stock option awards. At December 31, 2016, future stock compensation expense (net of estimated forfeitures) not yet recognized was $92,603 and will be recognized over a weighted average remaining vesting period of 3.5 years. A summary of stock option activity during the year ended December 31, 2016 and 2015 is as follows: Weighted Weighted Average Average Remaining Number of Exercise Contractual Shares Price Life (years) Outstanding at December 31, 2014 49,000 11.01 Granted 50,000 0.50 Exercised - - Forfeited (49,000 ) 11.92 Outstanding at December 31, 2015 50,000 $ 0.50 10.0 Granted 50,000 $ 1.03 Exercised - - Forfeited - - Outstanding at December 31, 2016 100,000 0.77 9.4 Exercisable at December 31, 2016 16,000 $ 0.60 9.1 The intrinsic value of the Company’s stock options outstanding was $22,500 and $55,500 at December 31, 2016 and 2015, respectively. Warrants During the three months ended March 31, 2015, the Company offered to reduce the exercise price of certain warrants of the Company to $0.50 per share as an incentive to the holders to exercise such warrants (“Warrant Price Reduction”). As a result of the Warrant Price Reduction, a total of 649,650 shares of our Common Stock were issued after exercise of these warrants in exchange for $324,825 of proceeds. The Company determined that this transaction did not constitute a modification under ASC 718-10 or ASC 505-50 as it met the scope exceptions for a transaction with an investor. Accordingly, no expense was recognized in connection with these transactions. In March 2015, the Company received aggregate proceeds of $700,000 in exchange for convertible notes and the issuance of 466,667 warrants with a five year life and an exercise price of $2.50 per share. The convertible notes are convertible into units, with each unit consisting of a share of common stock and a warrant with a five year life from the date of conversion and an exercise price of $1 per share, subject to certain anti-dilution provisions. On April 15, 2015, the Company offered to reduce the exercise price of certain warrants of the Company to $0.50 per share as an incentive to the holders to exercise such warrants (“April 2015 Warrant Price Reduction”). Through December 31, 2015, warrant holders exercised their warrants for a total of 1,178,786 shares of our Common Stock, for proceeds received in the amount of $589,393. As a result of the decrease in the warrant price, the exercise price of certain of the Company’s outstanding warrants will be permanently reduced to $0.50 per share pursuant to their terms and certain of those warrants have a provision which will cause them to increase in number by multiplying the number by a fraction equal to the original warrant exercise price divided by the new warrant exercise price. The Company determined that this transaction does not constitute a modification under ASC 718-10 or ASC 505-50 as it met the scope exceptions for a transaction with an investor or lender. Accordingly, no expense was recognized in connection with these transactions. On April 17, 2015, the Company amended the Engagement Agreement originally dated October 1, 2013, between the Company and Tobin Tao & Company, Inc. (“Tobin Tao”). This amendment grants Tobin Tao warrants to purchase 200,000 shares of the Company’s common stock at $0.50 per share. The anti-dilution features qualify these as a derivative instrument. The valuation of the derivative liability of the warrants was determined through the use of a Black Scholes options model for an amount of $102,654, which the Company believes approximates fair value. On May 26, 2015, the Company granted 250,000 warrants with a an exercise price of $0.50 and a five year term to Darren Ofsink in exchange for services. The anti-dilution features qualify these as a derivative instrument. The valuation of the derivative liability of the warrants was determined through the use of a Black Scholes options model for an amount of $128,317, which the Company believes approximates fair value. In June 2015, the Company received aggregate proceeds of $530,000 in exchange for convertible notes and the issuance of 530,000 warrants with a five year life and an exercise price of $0.50 per share. The convertible notes are convertible into units, with each unit consisting two shares of common stock and two warrants with a five year life from the date of conversion and an exercise price $0.50 per share, subject to certain anti-dilution provisions. During September 2015, the full principal balances of these notes were converted pursuant to the terms of the notes into shares of the Company’s common stock and warrants to purchase common stock. On June 30, 2015, the Company granted 700,000 warrants to two convertible debt holders in order to modify the outstanding convertible debt. An additional 1,400,000 warrants were issued as the modified notes were immediately converted. The warrants have a five year life and an exercise price of $0.50 per share. On September 1, 2015 the Company entered into an Employment Agreement (the “Employment Agreement”) with Mark Tobin in his capacity as the Company’s Chief Financial Officer. Pursuant to the Employment Agreement, on September 1, 2015 the Company issued Mr. Tobin warrants to purchase 1,500,000 shares of the Company’s common stock at $1.00 per share (the “Warrant Shares”). 375,000 of the Warrant Shares vested on September 1, 2015, an additional 375,000 warrant shares will vest on the first anniversary date of the Employment Agreement, an additional 375,000 warrant shares will vest on the second anniversary date of the Employment Agreement, and, an additional 375,000 warrant shares will vest on the third anniversary date of the Employment Agreement. Warrant expense of $1,063,148 and $324,851 was recognized during the years ended December 31, 2016 and 2015, respectively. The agreement contains an anti-dilution provision and therefore the exercise price at December 31, 2016 is $0.50 per share. During the three months ended September 30, 2015, the Company received aggregate proceeds of $377,500 in exchange for convertible notes and the issuance of 377,500 warrants with a five year life and an exercise price of $0.50 per share. The convertible notes are convertible into units, with each unit consisting two shares of common stock and two warrants with a five year life from the date of conversion and an exercise price $0.50 per share, subject to certain anti-dilution provisions. During September 2015, the aggregate principal and interest of certain convertible notes totaling $757,595 were converted pursuant to the terms of the notes into 1,515,190 shares of the Company’s common stock and 1,515,190 warrants to purchase common stock. On November 4, 2015, the Company entered into an amendment to the Independent Contractor Agreement (the “Amendment”) with a service provider pursuant to which the service provider is to be issued warrants to purchase 2,400,000 shares of the Company’s common stock at $1.00 per share (the “Warrant Shares”). 1,200,000 of the Warrant Shares vested on November 4, 2015, an additional 600,000 Warrant Shares vested on the first anniversary date of the Amendment, and an additional 600,000 Warrant Shares will vest on the second anniversary date of the Amendment. On November 5, 2015, the Company issued a warrant to purchase 3,000,000 shares of the Company’s $.0001 par value common stock to the Company’s Chief Executive Officer, Dean Ledger, in exchange for services already performed. The warrants are immediately vested, have an exercise price of $1.00 and have a 10 year term. On November 9, 2015, the Company issued a warrant to purchase 500,000 shares of the Company’s $.0001 par value common stock to Robert J. Fasnacht, our former Executive Vice President, in exchange for services already performed. The warrants are immediately vested, have an exercise price of $1.00 and have a 10 year term. During the three months ended December 31, 2015, the Company received aggregate proceeds of $486,549 in exchange for convertible notes and the issuance of 486,549 warrants with a five year life and an exercise price of $0.50 per share. The convertible notes are convertible into units, with each unit consisting two shares of common stock and two warrants with a five year life from the date of conversion and an exercise price $0.50 per share, subject to certain anti-dilution provisions. During the three months ended December 31, 2015, the aggregate principal and interest of certain convertible notes totaling $204,020 were converted pursuant to the terms of the notes into 408,040 shares of the Company’s common stock and 408,040 warrants to purchase common stock. See details in Note 6. During the year ended December 31, 2015, the Company sold an aggregate of 86,000 units, respectively, at $1.00 per unit for aggregate proceeds of $86,000. Each unit consisted of one common share and one warrant. Each warrant is exercisable for a period of five years from the date of issuance, at $1.00 per share. During the year ended December 31, 2015, the Company granted an additional 86,000 warrants to the investors due to the reset provision. During the year ended December 31, 2015, the Company issued promissory notes in aggregate of $675,000. 1,350,000 cashless warrants for the Company’s common shares were issued with the debt at a strike price of $0.50/share in lieu of cash interest. The relative fair value of the warrants of $463,575 was recognized as a debt discount which is being amortized on a straight-line basis over the term of the note. During the year ended December 31, 2015, the Company granted an additional 5,284,500 warrant to investors due to the reset provision. On May 13, 2016, the Company entered into an agreement with a service provider pursuant to which the service provider is to be issued warrants to purchase 1,000,000 shares of the Company’s common stock at $1.00 per share (the “Warrant Shares”). 500,000 of the Warrant Shares vested on May 13, 2016, an additional 250,000 warrant shares will vest on the first anniversary date of the agreement, an additional 250,000 Warrant Shares will vest on the second anniversary date of the agreement. The fair value of the first 500,000 Warrant Shares was determined to be $388,888 using the Black-Scholes option pricing model and was recognized as expense and as derivative liabilities during the year ended December 31, 2016. On May 13, 2016, the Company entered into an agreement with a service provider pursuant to which the service provider is to be issued warrants to purchase 200,000 shares of the Company’s common stock at $1.00 per share (the “Warrant Shares”). The Warrant Shares are immediately vested. The fair value of the Warrant Shares was determined to be $155,555 using the Black-Scholes option pricing model and was recognized as expense and as derivative liabilities during the year ended December 31, 2016. On September 23, 2016, the Company issued warrants to purchase 15,000 shares of the Company’s common stock at $1.00 per share to a consultant in exchange for services already performed. The warrants have a five year term and are immediately vested. The fair value of the warrants was determined to be $13,618 using the Black-Scholes option pricing model of which $13,618 was recognized as expense during the year ended December 31, 2016. During the year ended December 31, 2016, the Company issued a total of 4,972,993 warrants in relation to the conversion of certain promissory notes. See details in Note 6. During the year ended December 31, 2016, the aggregate principal and interest of certain convertible notes totaling $1,233,621 were converted pursuant to the terms of the notes into 2,646,199 shares of the Company’s common stock and 2,584,621 warrants to purchase common stock. See details in Note 6. During the year ended December 31, 2016, the Company issued a promissory note of $300,000. 600,000 cashless warrants for the Company’s common shares were issued with the debt at a strike price of $0.50/share in lieu of cash interest. The relative fair value of the warrants of $235,188 was recognized as a debt discount which is being amortized on a straight-line basis over the term of the note. See details in Note 6. The following summarizes the warrant activity for the years ended December 31, 2016 and 2015: Weighted Average Weighted Remaining Average Contractual Aggregate Number of Exercise Term Intrinsic Shares Price (in years) Value Outstanding as of December 31, 2014 21,332,333 $ 2.53 3.8 $ - Granted 15,481,234 0.75 Warrants issued related to reset provision 5,284,500 2.50 Expired (243,200 ) 3.00 Exercised (1,828,436 ) 2.41 Outstanding as of December 31, 2015 40,026,431 $ 1.83 4.6 $ 54,932,218 Granted 20,647,751 0.50 Expired (149,250 ) 7.13 Exercised (144,411 ) 0.50 Outstanding as of December 31, 2016 60,380,521 $ 0.73 $ 4.6 $ 57,361,495 Exercisable as of December 31, 2016 59,030,521 $ 0.73 $ 4.6 $ 57,361,495 The reset shares are the result of reducing the exercise price of the warrants issued under Pipe I from $2.50 to $0.50, and Pipe II from $2.50 to $1.00. The increase in shares offset the reduced exercise price therefore the net value of the Pipe I & Pipe II warrants remain constant in total. Derivative Liabilities - Warrants The anti-dilution features in the freestanding warrants issued in the year ended December 31, 2015 cause the instruments to no longer be indexed to the Company’s own stock and requires that they be accounted for as derivative liabilities based on guidance in FASB ASC 815, Derivatives and Hedging. The valuation of the derivative liability of the warrants was determined through the use of a Black Scholes options model, which the Company believes approximates fair value. Using this model, the Company had a balance of $847,791 at December 31, 2014. The Company determined a fair value of $1,423,303 at issuance date for warrants issued during the year ended December 31, 2015 of which $76,368 was reclassified from additional paid-in capital and $1,346,935 was recognized as compensation expense. The Company recorded the change in the fair value of the warrant liabilities recognizing a loss of $10,525,052 for the year ended December 31, 2015, to reflect the value of the warrant derivative liability of $12,796,146 at December 31, 2015. The Company determined a fair value of $1,104,343 at issuance date for warrants issued during the year ended December 31, 2016 of which $559,900 was reclassified from additional paid-in capital and $544,443 was recognized as compensation expense. The Company recorded the change in the fair value of the warrant liabilities recognizing a gain of $5,072,084 for the year ended December 31, 2016, to reflect the value of the warrant derivative liability of $8,828,405 at December 31, 2016. The warrants were valued using the Black-Scholes pricing model with the following assumptions: Year Ended December 31, 2016 2015 Volatility 129-.70 % - 192.70% 108.72% -132.58% Risk-free interest rate 0.44% - 2.45% 0.725% - 2.27% Expected term 2 - 10 years 3 - 10 years

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2016
Commitments and Contingencies [Abstract]
Commitments and Contingencies	Note 8. Commitments and Contingencies Sponsored Research and License Agreements Research and development of the Company’s high efficiency solar thin films and OPV technologies are conducted in collaboration with University partners through sponsored research agreements. The Company established direct research and development agreements with Michigan on June 16, 2016, which were amended on July 21, 2016, to provide engineering support and facility access associated with technology transfer and commercialization of its high efficiency thin film solar technologies. A separate Research Agreement, dated December 20, 2013, among the Company and USC (the “2013 Research Agreement”), governs research conducted by USC and Michigan on high efficiency thin film and OPV technologies. Michigan is a subcontractor to USC on this research agreement. Under the 2013 Research Agreement, the Company made a deposit of $550,000 (the “Deposit”) in early 2014. This Deposit was used by USC to pay for research costs and expenses as it incurred them, including payments to Michigan, during any billing quarter. When the Company pays the related quarterly billing, the funds go to replenish the Deposit back to the full amount of $550,000, which is to continue until the end of the 2013 Research Agreement. The 2013 Research Agreement expires on January 31, 2021. On August 8, 2016, the Company amended the 2013 Research Agreement with USC, suspending the agreement effective as of August 15, 2016. The Company requested this amendment to temporarily suspend its OPV-related sponsored research activities to reduce near-term expenditures while it seeks a development partner for OPV commercialization and to allow the Company to bring its account with USC current through a payment plan. The suspension is to continue until the date that is 30 days after expenses incurred by USC have been reimbursed by the Company. Under this amendment, the Company will repay expenses to USC in quarterly installments of $206,000 from November 2016 through February 2018, unless earlier repaid at the Company’s option. The amended agreement provides USC with the option to terminate the agreement upon any late installment payments. Under the Company’s currently effective License Agreement, as amended on August 22, 2016, among the Company and USC, Michigan, and Princeton (the “Fourth Amendment to License Agreement”), wherein the Company has obtained the exclusive worldwide license and right to sublicense any and all intellectual property resulting from the Company’s sponsored research agreements, we have agreed to pay for all reasonable and necessary out of pocket expenses incurred in the preparation, filing, maintenance, renewal and continuation of patent applications designated by the Company. In addition, the Company is required to pay to USC 3% of net sales of licensed products or licensed processes used, leased or sold by the Company, 3% of revenues received by the Company from the sublicensing of patent rights and 23% of revenues (net of costs and expenses, including legal fees) received by the Company from final judgments in infringement actions respecting the patent rights licensed under the agreement. A previous amendment to the License Agreement (the Third Amendment to License Agreement dated December 20, 2013) amended the minimum royalty section to eliminate the accrual of any such royalties until 2014. Furthermore, the amounts of the non-refundable minimum royalties, which would be applicable starting in 2014, were adjusted to be lower than the amounts in the previous License Agreement. The Fourth Amendment to the License Agreement sets out a payment schedule for the minimum royalties due in 2014 and 2015 to be paid in 2016 and 2017. Minimum royalties are as follows: Years ending December 31, 2017 65,000 2018 75,000 2019 100,000 2020 100,000 2021 100,000 2022 and thereafter 100,000 There is currently no ongoing research activity at Princeton related to the Company, although the Company maintains licensing rights to technology previously developed there. Lease Commitments In November 2013, the Company entered into a 60-month lease agreement for its corporation facility in Arizona. Total rent expense for the year ended December 31, 2016 and 2015 was $82,971 and $91,871, respectively. Future minimum lease payments are as follows: 2017 $ 84,233 2018 71,797 2019 - 2020 - 2021 - Thereafter - Total $ 156,030 Concentrations All of the Company’s revenue and accounts receivable are currently earned from one customer. Legal Matters On March 18, 2015, the Company received correspondence from the counsel of Mr. John Kuhns, the Company’s former Co-CEO and Executive Chairman alleging that Mr. Kuhns has “Good Reason” to terminate his Employment Agreement for an alleged failure to pay his salary in full. On March 30, 2015, Mr. Kuhns advised that if the alleged breaches of the Employment Agreement were not cured there was a possibility that he would pursue litigation. As of March 30, 2015, shareholders holding approximately 67.26% of the total shares of common stock of NanoFlex Power Corporation (the “Company,” “we,” “our” or “us”) that are entitled to vote on all Company matters approved by written consent the removal of John D. Kuhns from his position as a member of the Company’s Board of Directors. Mr. Kuhns’ removal was for “Cause” as defined under his Employment Agreement as amended and dated as of October 1, 2013 (the “Employment Agreement”). The removal arose as a result of his documented conduct and statements, which breached his fiduciary duties to the Company in order to advance personal monetary and other interests, and thereby threatened serious financial injury to the Company, its shareholders and its debtholders. On March 31, 2015, the Board of Directors terminated the Employment Agreement with Mr. Kuhns for Cause and removed him from his positions as Co-CEO, and from all other officer positions he held with the Company and its subsidiaries and affiliates, and all director positions with the Company’s subsidiaries and affiliates. On April 24, 2015, the Company received a letter from Mr. Kuhns’ counsel (the “Response Letter”) stating that Mr. Kuhns disagreed with statements in the Initial Filing regarding the circumstances of his removal as a director and officer. The Response Letter was accompanied by a copy of a complaint (the “Complaint”) filed by John D, Kuhns (the “Plaintiff”) in the United States District Court Southern District of New York against the Company, Mr. Dean L. Ledger, our current CEO and member of our Board of Directors, Mr. Robert J. Fasnacht, our current Executive Vice President and member of our Board of Directors and Mr. Ronald B. Foster, a shareholder of the Company (each, a “Defendant,” collectively, the “Defendants”). The Complaint alleges, among other things, that the Plaintiff was terminated by the Company in violation of Section 922 of the Dodd-Frank Act, that the Company wrongfully terminated the Employment Agreement, that the Defendants made false statements to shareholders regarding the Plaintiff, that the Defendants (other than the Company) tortuously interfered with the Plaintiff’s Employment Agreement, and that Mr. Ledger and Mr. Fasnacht breached their fiduciary duties to the Company and its shareholders. The Plaintiff seeks monetary damages, including (i) two (2) times of the alleged owed compensation to him, together with interest as well as litigation costs, expert witness fees and reasonable attorneys’ fees; (ii) damages for the alleged breach of the Employment Agreement by the Company, estimated to be at least $2 million, plus interest and attorney’s fees; (iii) an unspecified amount for his alleged libel claim; and (iv) damages for the alleged tortious interference with contract, including punitive damages of at least $2 million. The Plaintiff is also seeking a declaratory judgment, claiming that he was not terminated as a director and should continue to hold a seat on the Company’s Board of Directors. On September 3, 2015 the Company filed a Motion to Dismiss portions of the Complaint in the United States District Court Southern District of New York. The United States District Court Southern District of New York heard oral argument on the Motion to Dismiss on June 23, 2016, and at the conclusion took the Motion to Dismiss under advisement. The Court ruled on August 24, 2016, regarding the Motion to Dismiss, and granted the motion in part and denied the motion in part. The Court granted a dismissal of all claims against Mr. Foster and dismissal of the Plaintiff’s declaratory judgment claim. All other claims by the Plaintiff continue to be outstanding. The Company filed an answer to the Complaint on September 14, 2016, and the Plaintiff responded to the Company’s counter claims contained in the Company’s answer on November 7, 2016. The parties have exchanged document demands and the next phase of the case is discovery. The Company believes that the allegations in the Complaint to be without any merit and will vigorously defend against the claims.

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2016
Income Taxes [Abstract]
Income Taxes	Note 9. Income Taxes The Company has incurred losses since inception. As of December 31, 2016, the Company has net operating loss carry-forwards of approximately $65,552,428 that begin to expire in 2017. Pursuant to Sections 382 and 383 of the Internal Revenue Code, the utilization of NOLs and other tax attributes may be subject to substantial limitations if certain ownership changes occur during a three-year testing period (as defined by the Internal Revenue Code). A valuation allowance was established for all the net deferred tax assets because realization is not assured. The components of the deferred tax assets consist of the following: December 31, 2016 2015 Net operating losses $ 22,000,000 $ 21,000,000 Less: valuation allowance (22,000,000 ) (21,000,000 ) Net deferred tax assets $ - $ -

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 31, 2016
Subsequent Events [Abstract]
Subsequent Events	Note 10. Subsequent Events During January, 2017, the Company issued 107,000 shares of the Company’s Common Stock upon conversion of certain promissory notes. During January, 2017 the Company issued warrants to purchase 107,000 shares of its Common Stock related to the conversion of certain convertible notes. Such warrants have an exercise price of $.50 and a term of 5 years and a cashless conversion feature. On January 27, 2017, the Company entered into a note purchase agreement with an investor pursuant to which an investor purchased a promissory note from the Company in exchange for $200,000 and a warrant to purchase 400,000 shares of the company’s common stock with a $.50 exercise price and 5 year term. The Note automatically converted by its terms 30 days after issuance, on February 27, 2017, into an investment in the principal amount of the note in the Company’s convertible notes and warrants, upon automatic conversion, the investor was issued a one year promissory note convertible into shares of the Company’s Common Stock at a $.50 conversion price and 5 year warrants with an exercise price of $.50 and a cashless conversion feature. On January 27, 2017, the Company issued a Non-Convertible Promissory Note for $380,000 to an investor in exchange for $380,000. This note expires on the 4 month anniversary date of the issuance date, and in lieu of interest under the note, the Company agreed to pay the investor $19,000 in cash within three days of the expiration of such note. On February 2, 2017, the Company entered into a non-exclusive license agreement with SolAero for use of NanoFlex’s patented ND-ELO process and related technologies in the space and near-space fields of use. During February, 2017, the Company issued 64,800 shares of the Company’s Common Stock upon conversion of a certain promissory note. During February, 2017 the Company issued warrants to purchase 64,800 shares of its Common Stock related to the conversion of a certain convertible note. Such warrants have an exercise price of $.50 and a term of 5 years and a cashless conversion feature. On February 1, 2017, the Company issued warrants to purchase 30,000 shares of its Common Stock to a service provider in exchange for services provided to the Company. 5,000 of the warrants are to vest on February 28, 2017, and 5,000 warrants shall vest on the last date of each month following February 2017, until final vesting on July 31, 2107. The warrants have an exercise price of $0.50 and a 5 year term. On February 13, 2017, the Company issued 336,000 shares of the Company’s Common Stock to certain note holders for accrued interest. On March 6, 2017, the Company issued warrants to purchase 200,000 shares of its Common Stock to a service provider in exchange for services provided to the Company. The warrants have an exercise price of $0.50 and a 5 year term. On March 8, 2017, the Company entered into a note purchase agreement with an investor pursuant to which an investor purchased a promissory note from the Company in exchange for $200,000 and a warrant to purchase 400,000 shares of the company’s common stock with a $.50 exercise price and 5 year term. The Note automatically converts by its terms 30 days after issuance into an investment in the principal amount of the note in the Company’s convertible notes and warrants, upon automatic conversion, the investor is to be issued a one year promissory note convertible into shares of the Company’s Common Stock at a $.50 conversion price and 5 year warrants with an exercise price of $.50 and a cashless conversion feature. On March 9, 2017, the Company entered into note purchase agreements with two investors pursuant to whichinvestors purchased a promissory note from the Company in exchange for $100,000 and $150,000, respectively, and a warrant to purchase 200,000 and 300,000 shares of the company’s common stock, respectively, with a $.50 exercise price and 5 year term. The Note automatically converts by its terms 30 days after issuance into an investment in the principal amount of the note in the Company’s convertible notes and warrants, upon automatic conversion, the investor is to be issued a one year promissory note convertible into shares of the Company’s Common Stock at a $.50 conversion price and 5 year warrants with an exercise price of $.50 and a cashless conversion feature.

Summary of Significant Accoun17

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2016
Summary of Significant Accounting Policies [Abstract]
Cash and Cash Equivalents	Cash and Cash Equivalents For purposes of the statement of cash flows, the Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents.
Principles of Consolidation	Principles of Consolidation The consolidated financial statements include the accounts of the Company and its controlled subsidiaries. Intercompany transactions and balances are eliminated at consolidation. Equity investments in which we exercise significant influence, but do not control and are not the primary beneficiary, are accounted for using the equity method of accounting. Investments in which we do not exercise significant influence over the investee are accounted for using the cost method of accounting.
Accounts Receivable	Accounts Receivable Accounts receivable are carried at the original invoiced amount less an allowance for doubtful accounts based on the probability of future collection. Management reviews accounts receivable on a periodic basis to determine if any receivables will potentially be uncollectible. The Company reserves for receivables that are determined to be uncollectible, if any, in its allowance for doubtful accounts. After the Company has exhausted all collection efforts, the outstanding receivable is written off against the allowance.
Property and Equipment	Property and Equipment Property and equipment are stated at cost. Depreciation of property and equipment is provided using the straight-line method for financial reporting purposes at rates based on the estimated useful lives of the assets. Estimated useful lives range from three to eight years.
Impairment of Long-lived Assets	Impairment of Long-lived Assets The Company reviews the carrying value of its long-lived assets annually or whenever events or changes in circumstances indicate that the historical-cost carrying value of an asset may no longer be appropriate. The Company assesses recoverability of the asset by comparing the undiscounted future net cash flows expected to result from the asset to its carrying value. If the carrying value exceeds the undiscounted future net cash flows of the asset, an impairment loss is measured and recognized. An impairment loss is measured as the difference between the net book value and the fair value of the long-lived asset. Fair value is estimated based upon either discounted cash flow analysis or estimated salvage value.
Stock-Based Compensation	Stock-Based Compensation We account for stock based compensation in accordance with FASB ASC 718 which requires companies to measure the cost of employee services received in exchange for an award of an equity instrument based on the grant-date fair value of the award. Stock-based compensation expense is recognized on a straight-line basis over the requisite service period. We account for non-employee share-based awards in accordance with FASB ASC 505-50 under which the awards are valued at the earlier of a commitment date or upon completion of the services, based on the fair value of the equity instruments, and are recognized as expense over the service period.
Use of Estimates	Use of Estimates The preparation of these financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that may affect certain reported amounts and disclosures in the financial statements and accompanying notes. The significant estimates relate useful lives of software licenses, valuation of beneficial conversion feature on convertible debts, valuation of warrants and stock options, and valuation allowance for deferred income taxes. Actual results could differ from those estimates.
Concentration of Credit Risk and Significant Customers	Concentration of Credit Risk and Significant Customers Cash is maintained in bank accounts which, at times, may exceed federally insured limits. The Company has not experienced any losses in such accounts and does not believe it is exposed to any significant credit risk on cash. The Company’s revenue and accounts receivable are currently earned primarily from one customer.
Revenue Recognition	Revenue Recognition The Company recognizes revenue from its services when it is probable that the economic benefits associated with the transactions will flow to the Company and the amount of revenue can be measured reliably. This is normally demonstrated when: (i) persuasive evidence of an arrangement exists; (ii) the fee is fixed or determinable; (iii) performance of service has been delivered; and (iv) collection is reasonably assured. Revenue from our joint development agreements are recognized as services are provided and are limited to the total dollar amount specified in the agreement. R&D engineering services, through joint development agreements are a core component of NanoFlex’s operations and business model, since they are a necessary prerequisite to obtaining IP licensing agreements with customers. As such, R&D engineering services are expected to be a sustained revenue stream for NanoFlex as it works with additional customers and the services constitute a portion of the Company's ongoing central operations. The terms of the joint development agreement require the counterparty to pay Nanoflex up to $120,000 for the Company’s engineering related expenses upon successful completion of a proof of concept. Terms of the invoices are net 30 days. As of December 31, 2016, the Company has entered into one joint development agreement.
Research and Development	Research and Development Research and development costs are expensed in the period they are incurred in accordance with ASC 730, Research and Development unless they meet specific criteria related to technical, market and financial feasibility, as determined by management, including but not limited to the establishment of a clearly defined future market for the product, and the availability of adequate resources to complete the project. If all criteria are met, the costs are deferred and amortized over the expected useful life, or written off if a product is abandoned. At December 31, 2016 and 2015, the Company had no deferred development costs.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The carrying value of short-term financial instruments, including cash, accounts receivable, accounts payable and accrued expenses, and short-term borrowings approximate fair value due to the relatively short period to maturity for these instruments. The long-term borrowings approximate fair value since the related rates of interest approximates current market rates.
Income Taxes	Income Taxes Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. These assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which the temporary differences are expected to reverse. We have net operating loss carry-forwards available to reduce future taxable income. Future tax benefits for these net operating loss carry-forwards are recognized to the extent that realization of these benefits is considered more likely than not. To the extent that we will not realize a future tax benefit, a valuation allowance is established. We recognize and measure benefits for uncertain tax positions using a two-step approach. The first step is to evaluate the tax position taken or expected to be taken in a tax return by determining if the weight of available evidence indicates that is it more likely than not that the tax positions will be sustained upon audit, including resolution of any related appeals or litigation processes. For tax positions that are more likely than not to be sustained upon audit, the second step is to measure the tax benefit as the largest amount that is more than 50% likely to be realized upon settlement. Our practice is to recognize interest and/or penalties related to income tax matters in income tax expense. Significant judgment is required to evaluate uncertain tax positions. Evaluations are based upon a number of factors, including changes in facts or circumstances, changes in tax law, correspondence with tax authorities during the course of tax audits and effective settlement of audit issues. Changes in the recognition or measurement of uncertain tax positions could result in material increases or decreases in income tax expense in the period in which the change is made, which could have a material impact on our effective tax position.

Background, Basis of Presenta18

Background, Basis of Presentation (Tables)	12 Months Ended
	Dec. 31, 2016
Background, Basis of Presentation [Abstract]
Schedule of financial statements errors correction	As of December 31, 2015 As Reported Revision As Revised Conversion option derivative liability $ 8,145,160 $ (2,733,973 ) $ 5,411,187 Convertible debt, net of unamortized discounts 1,051,545 72,273 1,123,818 Total current liabilities 28,168,610 (2,661,700 ) 25,506,910 Total liabilities 28,168,610 (2,661,700 ) 25,506,910 Accumulated deficit (204,989,355 ) 3,484,877 (201,504,478 ) Additional paid in capital 176,932,064 (823,177 ) 176,108,887 Total stockholders' deficit (28,052,143 ) 2,661,700 (25,390,443 ) Year Ended December 31, 2015 As Reported Revision As Revised Loss on change in fair value of derivative $ (13,901,957 ) $ 3,708,739 $ (10,193,218 ) Interest expense (1,685,160 ) (223,862 ) (1,909,022 ) Total other expense (15,737,117 ) 3,484,877 (12,252,240 ) Net loss (26,801,396 ) 3,484,877 (23,316,519 ) Net loss per share (basic and diluted) (0.56 ) (0.07 ) (0.49 )

Fair Value of Financial Instr19

Fair Value of Financial Instruments (Tables)	12 Months Ended
	Dec. 31, 2016
Fair Value of Financial Instruments [Abstract]
Schedule of valuation of financial instruments at fair value	Fair Value Measurements as of Level 1 Level 2 Level 3 Assets None $ $ $ Total assets - - - Liabilities Warrant derivative liability - - 8,828,405 Conversion option derivative liability - - 3,156,736 Total liabilities - - 11,985,141 Fair Value Measurements as of Level 1 Level 2 Level 3 Assets None $ $ $ Total assets - - - Liabilities Warrant derivative liability - - 12,796,146 Conversion option derivative liability - - 5,411,187 Total liabilities - - 18,207,333
Schedule of reconciliation of changes in fair value of financial assets and liabilities	Significant Unobservable Inputs (Level 3) Year Ended December 31, 2016 2015 Beginning balance $ 18,207,333 $ 847,791 Change in fair value (7,326,535 ) 10,193,218 Additions reclassified from equity 559,900 5,819,389 Additions recognized as debt discounts - - Additions recognized as compensation expense 544,443 1,346,935 Ending balance $ 11,985,141 $ 18,207,333

Debt (Tables)

Debt (Tables)	12 Months Ended
	Dec. 31, 2016
Debt [Abstract]
Schedule of Valuation derivative liabilities attached to the convertible debt	Year Ended December 31, 2016 2015 Volatility 135.41% - 232.51% 135.41% - 197.50% Risk-free interest rate 0.45% - 1.47% 0.16% - 1.54% Expected term 1 - 4 years 0.25 - 4.25 years

Equity (Tables)

Equity (Tables)	12 Months Ended
	Dec. 31, 2016
Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Schedule of option /warrant valued using a Black-Scholes option pricing model with assumptions	Years Ended December 31, 2016 2015 Volatility 144.36 % 122.87 % Risk-free interest rate 1.32 % 1.91 % Expected term 6.06 years 6.06 years
Summary of stock option / warrant activity	Weighted Weighted Average Average Remaining Number of Exercise Contractual Shares Price Life (years) Outstanding at December 31, 2014 49,000 11.01 Granted 50,000 0.50 Exercised - - Forfeited (49,000 ) 11.92 Outstanding at December 31, 2015 50,000 $ 0.50 10.0 Granted 50,000 $ 1.03 Exercised - - Forfeited - - Outstanding at December 31, 2016 100,000 0.77 9.4 Exercisable at December 31, 2016 16,000 $ 0.60 9.1
Warrant [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Schedule of option /warrant valued using a Black-Scholes option pricing model with assumptions	Year Ended December 31, 2016 2015 Volatility 129-.70 % - 192.70 % 108.72% -132.58 % Risk-free interest rate 0.44% - 2.45 % .725% - 2.27 % Expected term 2 - 10 years 3 - 10 years
Summary of stock option / warrant activity	Weighted Average Weighted Remaining Average Contractual Aggregate Number of Exercise Term Intrinsic Shares Price (in years) Value Outstanding as of December 31, 2014 21,332,333 $ 2.53 3.8 $ - Granted 15,481,234 0.75 Warrants issued related to reset provision 5,284,500 2.50 Expired (243,200 ) 3.00 Exercised (1,828,436 ) 2.41 Outstanding as of December 31, 2015 40,026,431 $ 1.83 4.6 $ 54,932,218 Granted 20,647,751 0.50 Expired (149,250 ) 7.13 Exercised (144,411 ) 0.50 Outstanding as of December 31, 2016 60,380,521 $ 0.73 $ 4.6 $ 57,361,495 Exercisable as of December 31, 2016 59,030,521 $ 0.73 $ 4.6 $ 57,361,495

Commitments and Contingencies (

Commitments and Contingencies (Tables)	12 Months Ended
	Dec. 31, 2016
Commitments and Contingencies [Abstract]
Schedule of future minimum royalties	Years ending December 31, 2017 65,000 2018 75,000 2019 100,000 2020 100,000 2021 100,000 2022 and thereafter 100,000
Schedule of future minimum lease payments	2017 $ 84,233 2018 71,797 2019 - 2020 - 2021 - Thereafter - Total $ 156,030

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2016
Income Taxes [Abstract]
Schedule of components of the deferred tax assets	December 31, 2016 2015 Net operating losses $ 22,000,000 $ 21,000,000 Less: valuation allowance (22,000,000 ) (21,000,000 ) Net deferred tax assets $ - $ -

Background, Basis of Presenta24

Background, Basis of Presentation (Details) - USD ($)	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Statement of Financial Position [Abstract]
Conversion option derivative liability	$ 3,156,736	$ 5,411,187
Convertible debt, net of unamortized discounts	1,440,206	1,123,818
Total current liabilities	19,269,758	25,506,910
Total liabilities	19,269,758	25,506,910
Accumulated deficit	(208,569,839)	(201,504,478)
Additional paid-in capital	189,324,088	176,108,887
Total stockholders' deficit	$ (19,239,725)	(25,390,443)	$ (6,044,343)
As Reported [Member]
Statement of Financial Position [Abstract]
Conversion option derivative liability		8,145,160
Convertible debt, net of unamortized discounts		1,051,545
Total current liabilities		28,168,610
Total liabilities		28,168,610
Accumulated deficit		(204,989,355)
Additional paid-in capital		176,932,064
Total stockholders' deficit		(28,052,143)
Revision [Member]
Statement of Financial Position [Abstract]
Conversion option derivative liability		(2,733,973)
Convertible debt, net of unamortized discounts		72,273
Total current liabilities		(2,661,700)
Total liabilities		(2,661,700)
Accumulated deficit		3,484,877
Additional paid-in capital		(823,177)
Total stockholders' deficit		$ 2,661,700

Background, Basis of Presenta25

Background, Basis of Presentation (Details 1) - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Statement of Financial Position [Abstract]
Loss on change in fair value of derivative	$ 7,326,535	$ (10,193,218)
Interest expense	(4,152,353)	(1,909,022)
Total other expense	(582,804)	(12,252,240)
Net loss	$ (7,065,361)	$ (23,316,519)
Net loss per share (basic and diluted)	$ (0.12)	$ (0.49)
As Reported [Member]
Statement of Financial Position [Abstract]
Loss on change in fair value of derivative		$ (13,901,957)
Interest expense		(1,685,160)
Total other expense		(15,737,117,000)
Net loss		$ (26,801,396)
Net loss per share (basic and diluted)		$ (0.56)
Revision [Member]
Statement of Financial Position [Abstract]
Loss on change in fair value of derivative		$ 3,708,739
Interest expense		(223,862)
Total other expense		3,484,877
Net loss		$ 3,484,877
Net loss per share (basic and diluted)		$ (0.07)

Background, Basis of Presenta26

Background, Basis of Presentation (Details Textual)	Mar. 30, 2015	Sep. 24, 2013
Background, Basis of Presentation (Textual)
Percentage of equity interests	67.26%	100.00%

Going Concern (Details)

Going Concern (Details) - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Going Concern (Textual)
Working capital deficit	$ 19,246,667
Accumulated deficit	$ 208,569,839	$ 201,504,478
Operation requirment cost, description	The Company currently requires approximately $6 million to $8 million to continue its operations over the next twelve months.

Summary of Significant Accoun28

Summary of Significant Accounting Policies (Details)	12 Months Ended
	Dec. 31, 2016
Summary of Significant Accounting Policies (Textual)
Property and equipment, depreciation method	Straight-line method.
Property and equipment, estimated useful lives	Estimated useful lives range from three to eight years.
Income tax settlement amount, description	For tax positions that are more likely than not to be sustained upon audit, the second step is to measure the tax benefit as the largest amount that is more than 50% likely to be realized upon settlement.
Revenue recognition terms description	The terms of the joint development agreement require the counterparty to pay Nanoflex up to $120,000 for the Company's engineering related expenses upon successful completion of a proof of concept. Terms of the invoices are net 30 days.

Fair Value of Financial Instr29

Fair Value of Financial Instruments (Details) - USD ($)	Dec. 31, 2016	Dec. 31, 2015
Liabilities
Warrant derivative liability	$ 8,828,405	$ 12,796,146
Conversion option derivative liability	3,156,736	5,411,187
Fair Value, Inputs, Level 1 [Member]
Assets
None
Total assets
Liabilities
Warrant derivative liability
Conversion option derivative liability
Total liabilities
Fair Value, Inputs, Level 2 [Member]
Assets
None
Total assets
Liabilities
Warrant derivative liability
Conversion option derivative liability
Total liabilities
Fair Value, Inputs, Level 3 [Member]
Assets
None
Total assets
Liabilities
Warrant derivative liability	8,828,405	12,796,146
Conversion option derivative liability	3,156,736	5,411,187
Total liabilities	$ 11,985,141	$ 18,207,333

Fair Value of Financial Instr30

Fair Value of Financial Instruments (Details 1) - Fair Value, Inputs, Level 3 [Member] - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Beginning balance	$ 18,207,333	$ 847,791
Change in fair value	(7,326,535)	10,193,218
Additions reclassified from equity	559,900	5,819,389
Additions recognized as debt discounts
Additions recognized as compensation expense	544,443	1,346,935
Ending balance	$ 11,985,141	$ 18,207,333

Debt (Details)

Debt (Details) - Derivative Financial Instruments, Liabilities [Member]	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Maximum [Member]
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Volatility	232.51%	197.50%
Risk-free interest rate	1.47%	1.54%
Expected term	4 years	4 years 3 months
Minimum [Member]
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Volatility	135.41%	135.41%
Risk-free interest rate	0.45%	0.16%
Expected term	1 year	3 months

Debt (Details Textual)

Debt (Details Textual) - USD ($)	Mar. 09, 2017	Mar. 08, 2017	Mar. 06, 2017	Feb. 01, 2017	Dec. 27, 2016	Nov. 21, 2016	Nov. 07, 2016	Oct. 07, 2016	Sep. 23, 2016	Jul. 13, 2016	May 12, 2016	Mar. 07, 2016	Jan. 22, 2016	Nov. 05, 2015	Jul. 13, 2015	May 26, 2015	Apr. 30, 2015	Feb. 28, 2017	Jan. 31, 2017	Jan. 25, 2016	Oct. 19, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 19, 2014	Jul. 31, 2014	Feb. 26, 2014	Dec. 31, 2016	Jun. 30, 2016	Sep. 30, 2016	Dec. 31, 2015	Sep. 30, 2015	Dec. 31, 2015	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014	Jan. 27, 2017	Jan. 31, 2016	Jan. 06, 2016	Sep. 01, 2015	Jun. 29, 2015	Apr. 17, 2015	Apr. 15, 2015
Debt (Textual)
Notes payable to related parties																											$ 500,000			$ 670,848		$ 670,848	$ 500,000	$ 670,848
Outstanding debt																											243,208			150,000		150,000	243,208	150,000
Amortization of debt discounts																																	2,442,475	1,292,525
Unamortized discount, net																														113,253		113,253		113,253
Interest paid related parties																																	16,678	11,984
Borrowings on related party debt																																	1,875,000	625,000
Exercise price of warrants																							$ 0.50
Warrants issued for services																																	1,956,619	4,615,154
Accounts payable- related party																											2,470			62,469		62,469	2,470	62,469
Convertible notes payable																															$ 757,595
Fair value of warrants issued																																	1,104,343	1,423,303
Advances related party																											510,000			110,000		110,000	510,000	110,000
Conversion of debt instrument, value																																		$ 1,634,928
Conversion of debt instrument, shares																																		3,323,230
Loss on extinguishment of debt																																	(3,756,986)	$ (150,000)
Derivative liability value																											8,828,405			12,796,146		12,796,146	8,828,405	12,796,146
Reclassification of conversion options as derivative liabilities																																		5,743,021
Debt discount due to derivative liabilities
Interest expense of warrants related to conversion of debt																																	1,297,324	494,730
Convertible Debt, Current																											1,440,206			1,123,818		1,123,818	1,440,206	1,123,818
Beneficial conversion feature recognized as additional paid in capital																																	4,676,812	1,655,369
Proceeds from convertible notes																																	1,458,000	2,106,405
Subsequent Event [Member]
Debt (Textual)
Term of note																			5 years
Convertible notes payable																																				$ 380,000
Conversion of debt instrument, shares																		64,800	107,000
Warrants exercisable price per share																			$ 0.50
Warrants issued to purchase common stock																			107,000
Short Term Note Agreements [Member]
Debt (Textual)
Outstanding debt					$ 200,000	$ 300,000
Repayments of debt					$ 10,000	$ 15,000
Chief Financial Officer [Member]
Debt (Textual)
Accounts payable related parties																											2,470			62,469		62,469	2,470	62,469
Warrant [Member]
Debt (Textual)
Amortization of debt discounts																																	235,188
Unamortized discount, net																														$ 289,206		$ 289,206		$ 289,206
Debt instrument interest rate																					8.00%
Warrants issued for conversion of notes																						530,000								489,549
Exercise price of warrants																$ 0.50					$ 2.50	$ 0.50	$ 2.50							$ 0.50	$ 0.50	$ 0.50		$ 0.50							$ 0.50	$ 0.50
Convertible notes payable																														$ 204,020	$ 377,500	$ 204,020		$ 204,020
Fair value of warrants issued									$ 13,618																									463,575
Term of warrants																5 years						5 years	5 years							5 years	5 years
Conversion of debt instrument, value																						$ 530,000	$ 700,000										4,972,993	$ 675,000
Conversion of debt instrument, shares																					75,288													1,350,000
Fair value of beneficial conversion feature																															$ 2,360,259
Loss on derivative																														$ 2,836,599	4,892,969			$ 4,892,969
Debt discount due to derivative liabilities																														197,343	$ 102,875,000
Warrants exercisable price per share																																		$ 1
Additional warrant expense																																	1,063,148	$ 324,851
Proceeds from convertible notes																														486,549
Warrant [Member] | Subsequent Event [Member]
Debt (Textual)
Term of note																		5 years
Warrants exercisable price per share	$ 0.50	$ 0.50	$ 0.50	$ 0.50														$ 0.50
Warrants issued to purchase common stock			200,000	30,000														64,800
Warrant [Member] | Chief Executive Officer [Member]
Debt (Textual)
Term of warrants														10 years
Warrants exercisable price per share														$ 1
Warrant [Member] | Chief Financial Officer [Member]
Debt (Textual)
Exercise price of warrants																																							$ 1
Common Stock [Member]
Debt (Textual)
Principal amount of debt																					$ 37,644
Exercise price of warrants																					$ 0.50
Warrants issued for services
Conversion of debt instrument, value																					$ 37,644
Conversion of debt instrument, shares																					37,644
Fair value of beneficial conversion feature
Warrants exercisable price per share																																		$ 1
Beneficial conversion feature recognized as additional paid in capital
Notes Payable [Member]
Debt (Textual)
Term of note																																		120 days
Outstanding debt																											400,000			150,000		150,000	400,000	$ 150,000
Amortization of debt discounts																																	78,396	$ 45,243
Unamortized discount, net																											$ 156,792						$ 156,792
Debt instrument interest rate																											10.00%						10.00%
Warrants issued for conversion of notes																																	600,000	100,000
Debt instrument description																																		0.50
Fair value of warrants issued																																	$ 235,188	$ 45,243
Share price																											$ 0.50						$ 0.50
Prommisory notes issued																																	$ 300,000	50,000
Outstanding balance of notes payable																																		150,000	100,000
Notes Payable [Member] | Chief Executive Officer [Member]
Debt (Textual)
Outstanding debt																											$ 100,000,000						$ 100,000,000
Debt instrument interest rate																											0.50%						0.50%
Notes Payable [Member] | President [Member]
Debt (Textual)
Outstanding debt																											$ 100,000,000						$ 100,000,000
Debt instrument interest rate																											0.50%						0.50%
Notes Payable - Related Party [Member]
Debt (Textual)
Principal amount of debt																														625,000		625,000		625,000
Notes payable to related parties																														670,848		670,848		670,848	150,000
Amortization of debt discounts																																	$ 173,948
Unamortized discount, net																											$ 0			$ 104,152		$ 104,152	0	$ 104,152
Debt instrument interest rate																	4.00%
Borrowings on related party debt																										$ 150,000
Convertible notes payable maturity date																	Feb. 26, 2016
Warrants issued for conversion of notes																																		1,250,000
Interest due to be repaid																																		$ 314,180
Debt instrument description																										Under the terms of this agreement, this note is due to be repaid within 6 months of funding.								Notes #1 to #4 and Note #5 shall be collectively referred to herein as the "$2M Notes."
Exercise price of warrants																																						$ 0.50
Fair value of warrants issued																																		$ 996,178
Accrued interest																																					$ 509
Share price																														$ 0.50		$ 0.50		$ 0.50
Prommisory notes issued																																		$ 625,000
Outstanding balance of notes payable																																	500,000	670,848
Net of unamortized discounts																														$ 104,152		$ 104,152		$ 104,152	0
Notes Payable - Related Party [Member] | Note Conversion Agreement [Member]
Debt (Textual)
Principal amount of debt													$ 2,000,000
Unamortized discount, net													926,382
Warrants issued for conversion of notes																				4,320,000
Exercise price of warrants																				$ 0.50
Fair value of warrants issued													2,236,921
Term of warrants																				10 years
Conversion of debt instrument, value																				$ 160,000
Conversion of debt instrument, shares																				320,000
Loss on extinguishment of debt													3,163,303
Fair value of beneficial conversion feature													995,171							$ 1,004,829
Issuance of private placement													$ 2,000,000
Notes Payable - Related Party [Member] | Subsequent Event [Member]
Debt (Textual)
Warrants issued for conversion of notes																			2,750,000
Prommisory notes issued																			$ 1,375,000
Notes Payable - Related Party [Member] | Maximum [Member]
Debt (Textual)
Term of note																																		150 days
Notes Payable - Related Party [Member] | Minimum [Member]
Debt (Textual)
Term of note																																		120 days
Advances - Related Party [Member] | Chief Executive Officer [Member]
Debt (Textual)
Interest paid related parties																																	16,678	$ 7,989
Advance from related party																											730,000			212,350		212,350	730,000	212,350
Advance repaid																																	330,000	530,500
Advances related party																											510,000			$ 110,000		110,000	510,000	110,000
Convertible Notes Payable [Member]
Debt (Textual)
Common shares issued for conversion																														408,040
Principal amount of debt																						530,000	700,000	$ 300,000						$ 914,049		914,049		914,049
Notes payable to related parties																											$ 2,000,000						2,000,000
Term of note								1 year		1 year																	1 year		1 year
Amortization of debt discounts																						$ 85,749	$ 225,426	$ 130,915									2,196,621	933,103	4,304
Unamortized discount, net																											$ 343,294			$ 457,576		$ 457,576	$ 343,294	$ 457,576	0
Debt instrument interest rate								8.00%		8.00%		8.00%										8.00%	8.00%	8.00%			8.00%	8.00%	8.00%	8.00%		8.00%	8.00%	8.00%
Borrowings on related party debt																									$ 500,000
Convertible notes payable maturity date																						Jun. 30, 2016	Mar. 31, 2016	Dec. 19, 2015	Jul. 21, 2015
Warrants purchase price																								$ 1
Unsecured note conversion price																									$ 1.25
Warrants exercisable term																								5 years
Warrants issued for conversion of notes								200,000		500,000		80,000										530,000	466,667	200,000			158,500	375,000	244,500			914,049
Interest due to be repaid																									$ 16,500
Increase in interest amount																									25,000
Debt instrument description								The convertible note has a principal amount of $100,000, includes the issuance of 100,000 additional warrants, interest of 8% per annum, a maturity date of one year and is convertible into 200,000 units, with each unit consisting of a share of common stock and a warrant with a five year life from the date of conversion and an exercise price of $0.50 per share, subject to certain anti-dilution provisions.		The convertible note has a principal amount of $500,000, includes the issuance of 500,000 additional warrants, interest of 8% per annum, a maturity date of one year and is convertible into 1,000,000 units, with each unit consisting of a share of common stock and a warrant with a five year life from the date of conversion and an exercise price of $0.50 per share, subject to certain anti-dilution provisions.													These notes were modified on June 29, 2015 to change the conversion price and exercise price to $0.50 per share.	These notes were modified on June 29, 2015 to change the conversion price and exercise price to $0.50 per share.
Exercise price of warrants								$ 0.50		$ 0.50		$ 0.50										$ 0.50	$ 2.50	$ 2.50			$ 0.50	$ 0.50	$ 0.50	$ 0.50		$ 0.50	$ 0.50	$ 0.50
Warrants issued for services																						$ 80,643	$ 137,863	$ 71,369	$ 106,510
Convertible notes payable												$ 80,000										350,000					$ 1,123,818	$ 375,000		$ 1,051,545		$ 1,051,545	$ 1,123,818	$ 1,051,545
Fair value of warrants issued							$ 21,526	$ 52,848		$ 161,010
Term of warrants												5 years													5 years			5 years				5 years
Accrued interest																						50,000					$ 89,480			26,687		$ 26,687	89,480	26,687
Conversion of debt instrument, value								$ 100,000		$ 500,000												$ 530,000	$ 700,000	$ 300,000								$ 914,049	$ 1,233,621	$ 1,634,928
Conversion of debt instrument, shares								200,000		1,000,000												1,060,000	700,000	300,000	700,000		317,000		489,000			1,728,098	2,646,199	3,323,230
Loss on extinguishment of debt																									$ 150,000
Fair value of beneficial conversion feature								$ 13,209		$ 116,754												$ 5,106	$ 87,563	$ 59,546	6,743									$ 494,730
Derivative liability value																														1,008,119		$ 1,008,119		$ 1,008,119
Beneficial conversion feature recognized as additional paid in capital																											$ 48,508		$ 73,653			172,869
Additional warrant expense								$ 12,416		104,860		$ 20,897										$ 186,605	$ 206,620	$ 96,771			45,064	$ 108,286	68,012
Warrants issued to purchase common stock																																	2,646,199	3,323,230
Proceeds from convertible notes												$ 80,000															$ 158,500	$ 375,000	$ 244,500
Fair value of warrants issued with debt							100,000	200,000				80,000															158,500	375,000	244,500
Maturity date, description												One year																One year
Conversion of units, shares												160,000																750,000
Fair value of the conversion options												$ 20,898																$ 108,291
Debt discount								$ 74,374		278,386		$ 38,205															$ 64,927	$ 158,423	$ 102,835
Convertible note										$ 500,000																	158,500		$ 244,500	594,498		$ 594,498	$ 158,500	$ 594,498
Additonal issuance of warrants										500,000
Convertible Notes Payable [Member] | Short Term Note Agreements [Member]
Debt (Textual)
Principal amount of debt																									$ 250,000
Convertible Notes Payable [Member] | Warrant [Member]
Debt (Textual)
Amortization of debt discounts																														$ 489,549
Debt instrument interest rate																														8.00%		8.00%		8.00%
Warrants issued for conversion of notes																														486,549
Term of warrants																														5 years
Conversion of debt instrument, value																														$ 486,549
Conversion of debt instrument, shares																														973,098
Loss on derivative																														$ 2,639,256
Common stock issued to warrants purchase, shares																															1,515,190
Additional warrant expense																											146,682
Convertible Notes Payable [Member] | Common Stock [Member]
Debt (Textual)
Common shares issued for conversion																														408,040	1,515,190
Principal amount of debt																														$ 486,549		$ 486,549		$ 486,549
Interest paid related parties																														$ 14,092
Exercise price of warrants																														$ 0.50		$ 0.50		$ 0.50
Conversion of debt instrument, value																														$ 189,928
Conversion of debt instrument, shares																														408,040
Common stock issued to warrants purchase, shares																														408,040	1,515,190
Convertible Notes Payable - Related Party [Member]
Debt (Textual)
Loss on debt extinguishment											$ 44,044
Debt instrument interest rate											8.00%
Unsecured note conversion price											$ 0.50
Fair value of warrants issued											$ 50,000
Term of warrants											5 years
Warrants exercisable price per share											$ 0.50
Beneficial conversion feature recognized as additional paid in capital											$ 54,487
Additional warrant expense											$ 12,415
Convertible Notes Payable One [Member]
Debt (Textual)
Exercise price of warrants																																								$ 0.50
Convertible Notes Payable Two [Member]
Debt (Textual)
Principal amount of debt																															$ 745,000
Interest due to be repaid																															12,595
Derivative liability value																															$ 3,670,697
Convertible Notes Payable Five [Member]
Debt (Textual)
Amortization of debt discounts																														$ 957,512
Convertible Notes Payable Seven [Member]
Debt (Textual)
Amortization of debt discounts																																			4,304
Unamortized discount, net																																			$ 0
Derivative Liabilities And Convertible Notes [Member]
Debt (Textual)
Reclassification of conversion options as derivative liabilities															$ 5,743,021
Fair value of convertible feature															3,132,526
Fair value of the derivative liabilities																											$ 3,156,736			$ 5,411,187		$ 5,411,187	3,156,736	$ 5,411,187
Gain on fair value of conversion option derivative liabilities															$ 2,610,495
Recognized gain on derivative																																	$ 2,254,451	$ 331,834

Equity (Details)

Equity (Details) - Stock Options [Member]	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Volatility	144.36%	122.87%
Risk-free interest rate	1.32%	1.91%
Expected term	6 years 22 days	6 years 22 days

Equity (Details 1)

Equity (Details 1) - Stock Options [Member] - $ / shares	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Number of Shares
Number of Shares, Outstanding	50,000	49,000
Number of Shares, Granted	50,000	50,000
Number of Shares, Exercised
Number of Shares, Forfeited		(49,000)
Number of Shares, Outstanding	100,000	50,000
Number of Shares, Exercisable	16,000
Weighted Average Exercise Price
Weighted Average Exercise Price, Outstanding	$ 0.50	$ 11.01
Weighted Average Exercise Price, Granted	1.03	0.50
Weighted Average Exercise Price, Exercised
Weighted Average Exercise Price, Forfeited		11.92
Weighted Average Exercise Price, Outstanding	0.77	$ 0.50
Weighted Average Exercise Price, Exercisable	$ 0.60
Weighted Average Remaining Contractual Life (years)
Weighted Average Remaining Contractual Life (years), Outstanding	9 years 4 months 24 days	10 years
Weighted Average Remaining Contractual Life (years), Exercisable	9 years 1 month 6 days

Equity (Details 2)

Equity (Details 2) - Warrant [Member] - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Number of Shares
Number of Shares, Outstanding	40,026,431	21,332,333
Number of Shares, Granted	20,647,751	15,481,234
Number of Shares, Warrants issued related to reset provision		5,284,500
Number of Shares, Expired	(149,250)	(243,200)
Number of Shares, Exercised	(144,411)	(1,828,436)
Number of Shares, Outstanding	60,380,521	40,026,431
Number of Shares, Exercisable	59,030,521
Weighted Average Exercise Price
Weighted Average Exercise Price, Outstanding	$ 1.83	$ 2.53
Weighted Average Exercise Price, Granted	0.50	0.75
Weighted Average Exercise Price, Warrants issued related to reset provision		2.50
Weighted Average Exercise Price, Expired	7.13	3
Weighted Average Exercise Price, Exercised	0.50	2.41
Weighted Average Exercise Price, Outstanding	0.73	$ 1.83
Weighted Average Exercise Price, Exercisable	$ 0.73
Weighted Average Remaining Contractual Term (in years)
Weighted Average Remaining Contractual Term (in years), Outstanding	4 years 7 months 6 days	3 years 9 months 18 days
Weighted Average Remaining Contractual Term (in years), Exercisable	4 years 7 months 6 days
Aggregate Intrinsic Value
Aggregate Intrinsic Value, Outstanding	$ 54,932,218
Aggregate Intrinsic Value, Outstanding	57,361,495	$ 54,932,218
Aggregate Intrinsic Value, Exercisable	$ 57,361,495

Equity (Details 3)

Equity (Details 3) - Warrant [Member]	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Volatility	129.70%	108.72%
Risk-free interest rate	0.44%	0.725%
Expected term	2 years	3 years
Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Volatility	192.70%	132.58%
Risk-free interest rate	2.45%	2.27%
Expected term	10 years	10 years

Equity (Details Textual)

Equity (Details Textual)	Sep. 23, 2016USD ($)$ / sharesshares	May 13, 2016USD ($)$ / sharesshares	Dec. 09, 2015USD ($)$ / sharesshares	Nov. 09, 2015$ / sharesshares	Nov. 06, 2015USD ($)shares	Nov. 05, 2015$ / sharesshares	Nov. 04, 2015$ / sharesshares	Sep. 01, 2015$ / sharesshares	May 26, 2015USD ($)$ / sharesshares	Oct. 03, 2016shares	Dec. 23, 2015shares	Oct. 19, 2015USD ($)$ / sharesshares	Jun. 30, 2015USD ($)Holders$ / sharesshares	Apr. 15, 2015USD ($)$ / sharesshares	Mar. 31, 2015USD ($)$ / sharesshares	Apr. 28, 2013shares	Dec. 31, 2015USD ($)$ / shares$ / pureshares	Sep. 30, 2015USD ($)$ / sharesshares	Mar. 31, 2015USD ($)$ / sharesshares	Dec. 31, 2016USD ($)$ / sharesshares	Dec. 31, 2015USD ($)$ / shares$ / pureshares	Dec. 31, 2014USD ($)shares	Apr. 17, 2015USD ($)$ / sharesshares
Equity (Textual)
Amortization of debt discounts																				$ 2,442,475	$ 1,292,525
Common shares issued for payment of interest | shares																	53,374				53,374
Warrants and common shares issued for accrued interest																					$ 26,687
Common stock returned and cancelled for issuance of convertible note																					(37,644)
Common stock issued for services																					350,000
Proceeds from issuance of warrants																					914,220
Warrants to purchase common stock | shares																		1,515,190
Derivative liability																						$ 847,791
Conversion of debt instrument, value																					$ 1,634,928
Conversion of debt instrument, shares | shares																					3,323,230
Proceeds from exercise of warrants																				72,205	$ 914,220
Exercise price of warrants | $ / shares															$ 0.50				$ 0.50
Warrants exercise price subject to certain anti-dilution provisions | $ / shares																	$ 1
Principal balances of notes																		$ 757,595
Issued common stock convertible notes, shares | shares																		1,515,190
Fair value of warrants issued																				1,104,343	$ 1,423,303
Additional warrants issued to investors | shares																					5,284,500
Gain on change in fair value of derivative																				7,326,535	$ (10,193,218)
Reclassification of warrants as derivative liabilities																				559,900	76,368
Proceeds exchange for convertible notes																				1,458,000	2,106,405
Warrant derivative liability																	$ 12,796,146			8,828,405	12,796,146
Compensation expense																				544,443	1,346,935
Warrants issued for interest expense																				6,023
Promissory note																				300,000
Robert J. Fasnacht [Member]
Equity (Textual)
Common stock price per share | $ / shares			$ 0.0001
Warrant [Member]
Equity (Textual)
Sale of common shares, shares | shares																					86,000
Sale of common shares, value																					$ 86,000
Sale of stock, per share price | $ / shares																	$ 1				$ 1
Sale of stock and warrant, description																					Each unit consisted of one common share and one warrant.
Amortization of debt discounts																				235,188
Warrant exercisable period												5 years									5 years
Warrants exercisable price per share | $ / shares																					$ 1
Additional warrant expense																				$ 1,063,148	$ 324,851
Number of common shares exercised | shares																				(144,411)	(1,828,436)
Interest rate												8.00%
Common stock price per share | $ / shares	$ 1						$ 1
Fair value shares and warrants			$ 35,468
Stock and warrants to purchase common stock | shares																				20,647,751	15,481,234
Stock options cancelled during the period | shares																				149,250	243,200
Maximum term of options																				4 years 7 months 6 days
Stock options outstanding intrinsic value																	$ 54,932,218			$ 57,361,495	$ 54,932,218
Warrants exercised to total shares of common stock | shares														1,178,786
Proceeds from issuance of warrants														$ 589,393
Warrants to purchase common stock | shares	15,000						2,400,000										408,040			2,584,621	408,040		200,000
Number of warrants issued | shares									250,000				700,000		466,667		486,549		466,667		486,549
Derivative liability									$ 128,317														$ 102,654
Common stock issued on exercise of warrants | shares																			649,650
Warrants issued for conversion of notes | shares													530,000				489,549
Conversion of debt instrument, value													$ 530,000		$ 700,000					$ 4,972,993	$ 675,000
Conversion of debt instrument, shares | shares												75,288									1,350,000
Additional warrant issued | shares													1,400,000
Number of warrant shares vested | shares							1,200,000
Proceeds from exercise of warrants																		$ 377,500	$ 324,825
Term of warrants									5 years				5 years		5 years		5 years	5 years
Exercise price of warrants | $ / shares									$ 0.50			$ 2.50	$ 0.50	$ 0.50	$ 2.50		$ 0.50	$ 0.50	$ 2.50		$ 0.50		$ 0.50
Warrants exercise price subject to certain anti-dilution provisions | $ / shares																		$ 0.50
Principal balances of notes																	$ 204,020	$ 377,500			$ 204,020
Issued common stock convertible notes, shares | shares																	408,040			2,646,199
Fair value of warrants issued	$ 13,618																				$ 463,575
Additional warrants issued to investors | shares																					86,000
Gain on change in fair value of derivative																					$ 10,525,052
Convertible note conversion, description													The convertible notes are convertible into units, with each unit consisting two shares of common stock and two warrants with a five year life from the date of conversion and an exercise price $0.50 per share, subject to certain anti-dilution provisions.		The convertible notes are convertible into units, with each unit consisting of a share of common stock and a warrant with a five year life from the date of conversion and an exercise price of $1 per share, subject to certain anti-dilution provisions.		The convertible notes are convertible into units, with each unit consisting two shares of common stock and two warrants with a five year life from the date of conversion and an exercise price $0.50 per share, subject to certain anti-dilution provisions.	The convertible notes are convertible into units, with each unit consisting two shares of common stock and two warrants with a five year life from the date of conversion and an exercise price $0.50 per share, subject to certain anti-dilution provisions.
Number of convertible debt | Holders													2
Proceeds exchange for convertible notes																	$ 486,549
Shares issued for cashless warrant | shares																				600,000	1,350,000
Aggregate amount of promissory notes																	$ 675,000				$ 675,000
Common stock strike price																	0.50				0.50
Recognize Black-Scholes option pricing model expenses	$ 13,618
Aggregate principal amount of convertible notes																				$ 1,233,621
Aggregate interest amount of convertible notes																				1,233,621
Warrant [Member] | First Anniversary [Member]
Equity (Textual)
Number of warrant shares vested | shares		250,000					600,000
Warrant [Member] | Second Anniversary [Member]
Equity (Textual)
Number of warrant shares vested | shares		250,000					600,000
Warrant [Member] | Service Provider Agreement [Member]
Equity (Textual)
Common stock price per share | $ / shares		$ 1
Warrants to purchase common stock | shares		1,000,000
Number of warrant shares vested | shares		500,000
Determination of fair value		The fair value of the first 500,000 Warrant Shares was determined to be $388,888 using the Black-Scholes option pricing model and was recognized as expense and as derivative liabilities during the year ended December 31, 2016.
Recognize Black-Scholes option pricing model expenses		$ 388,888
Warrant [Member] | Service Provider Agreement 1 [Member]
Equity (Textual)
Common stock price per share | $ / shares		$ 1
Warrants to purchase common stock | shares		200,000
Determination of fair value		The fair value of the Warrant Shares was determined to be $155,555 using the Black-Scholes option pricing model and was recognized as expense and as derivative liabilities during the year ended December 31, 2016.
Recognize Black-Scholes option pricing model expenses		$ 155,555
Warrant [Member] | Mr.Tobin [Member]
Equity (Textual)
Warrants to purchase common stock | shares								1,500,000
Number of warrant shares vested | shares								375,000
Exercise price of warrants | $ / shares								$ 1
Warrant [Member] | Mr.Tobin [Member] | First Anniversary [Member]
Equity (Textual)
Number of warrant shares vested | shares								375,000
Warrant [Member] | Mr.Tobin [Member] | Second Anniversary [Member]
Equity (Textual)
Number of warrant shares vested | shares								375,000
Warrant [Member] | Mr.Tobin [Member] | Third Anniversary [Member]
Equity (Textual)
Number of warrant shares vested | shares								375,000
Warrant [Member] | Robert J. Fasnacht [Member]
Equity (Textual)
Warrants exercisable price per share | $ / shares				$ 1
Common stock price per share | $ / shares				$ 0.0001
Warrants to purchase common stock | shares			500,000	500,000
Term of warrants				10 years
Warrant [Member] | Chief Executive Officer [Member]
Equity (Textual)
Warrants exercisable price per share | $ / shares						$ 1
Common stock price per share | $ / shares						$ 0.0001
Warrants to purchase common stock | shares						3,000,000
Term of warrants						10 years
Common Stock [Member]
Equity (Textual)
Sale of common shares, shares | shares																					86,000
Sale of common shares, value																					$ 86,000
Sale of stock, per share price | $ / shares																	$ 1				$ 1
Sale of stock and warrant, description																					Each unit consisted of one common share and one warrant.
Warrant exercisable period			10 years									5 years									5 years
Warrants exercisable price per share | $ / shares																					$ 1
Number of common shares exercised | shares			250,000																		1,828,437
Common stock returned and cancelled for issuance of convertible note																					$ (7)
Number of common stock cancelled | shares												75,288									(75,288)
Common stock issued for services (in shares) | shares					350,000																350,000
Common stock issued for services					$ 350,000																$ 35
Common stock issued for shares and warrants | shares			100,000																		1,828,437
Common stock price per share | $ / shares			$ 0.50
Fair value shares and warrants			$ 14,532
Proceeds from issuance of warrants			50,000
Conversion of debt instrument, value												$ 37,644
Conversion of debt instrument, shares | shares												37,644
Proceeds from exercise of warrants			$ 50,000
Exercise price of warrants | $ / shares												$ 0.50
Principal amount of debt												$ 37,644
Warrants issued for interest expense
Common Stock and Warrants [Member]
Equity (Textual)
Common stock issued for shares and warrants | shares																				245,878
Fair value shares and warrants																				$ 617,175
Warrants to purchase common stock | shares																				426,741
Common stock issued on exercise of warrants | shares																				144,411
Proceeds from exercise of warrants																				$ 67,536
Exercise price of warrants | $ / shares																				$ 0.50
Issued common stock convertible notes, shares | shares																				2,646,199
Fair value of warrants issued																				$ 72,205
Loss on extinguishment of liability																				549,639
Issued common stock convertible notes, value																				1,233,621
Debt instrument, accrued interest																				$ 89,480
Common Stock and Warrants One [Member]
Equity (Textual)
Common stock issued for shares and warrants | shares																				1,434,076
Warrants to purchase common stock | shares																				4,546,252
Proceeds from exercise of warrants																				$ 663,922
Pipe I [Member] | Warrant [Member] | Minimum [Member]
Equity (Textual)
Warrants exercisable price per share | $ / shares																				$ 0.50
Pipe I [Member] | Warrant [Member] | Maximum [Member]
Equity (Textual)
Warrants exercisable price per share | $ / shares																				2.50
Pipe II [Member]
Equity (Textual)
Sale of stock, per share price | $ / shares																	1				$ 1
Pipe II [Member] | Warrant [Member] | Minimum [Member]
Equity (Textual)
Warrants exercisable price per share | $ / shares																				1
Pipe II [Member] | Warrant [Member] | Maximum [Member]
Equity (Textual)
Warrants exercisable price per share | $ / shares																				$ 2.50
PIPE II investors [Member]
Equity (Textual)
Sale of common shares, shares | shares																					1,554,500
Sale of stock, per share price | $ / shares																	$ 1.25				$ 1.25
2013 Stock Option Plan [Member]
Equity (Textual)
Stock and warrants to purchase common stock | shares																2,000,000
Maximum term of options																10 years
Stock Options [Member]
Equity (Textual)
Number of common shares exercised | shares
Stock and warrants to purchase common stock | shares										50,000	50,000									50,000	50,000
Stock options cancelled during the period | shares																					49,000
Stock option vested | shares										1,000	1,000
Options, expiration date										Dec. 31, 2026	Dec. 31, 2025
Maximum term of options										50 months	50 months									9 years 1 month 6 days	10 years
Stock option awards expenses																				$ 19,157	$ 364
Future stock compensation expense																				$ 92,603
Weighted average remaining vesting period																				3 years 6 months
Stock options outstanding intrinsic value																	$ 55,500			$ 22,500	$ 55,500

Commitments and Contingencies38

Commitments and Contingencies (Details)	Dec. 31, 2016USD ($)
Commitments and Contingencies [Abstract]
2,017	$ 65,000
2,018	75,000
2,019	100,000
2,020	100,000
2,021	100,000
2022 and thereafter	$ 100,000

Commitments and Contingencies39

Commitments and Contingencies (Details 1)	Dec. 31, 2016USD ($)
Schedule of future minimum lease payments
2,017	$ 84,233
2,018	71,797
2,019
2,020
2,021
Thereafter
Total	$ 156,030

Commitments and Contingencies40

Commitments and Contingencies (Details Textual) - USD ($)	Aug. 22, 2016	Aug. 08, 2016	Apr. 24, 2015	Dec. 20, 2013	Nov. 30, 2013	Dec. 31, 2016	Dec. 31, 2015	Mar. 30, 2015	Sep. 24, 2013
Commitments and Contingencies (Textual)
Rent expense						$ 82,971	$ 91,871
Percentage of the total shares of common stock								67.26%	100.00%
Description of Plaintiff compensation			The Plaintiff seeks monetary damages, including (i) two (2) times of the alleged owed compensation to him, together with interest as well as litigation costs, expert witness fees and reasonable attorneys' fees; (ii) damages for the alleged breach of the Employment Agreement by the Company, estimated to be at least $2 million, plus interest and attorney's fees; (iii) an unspecified amount for his alleged libel claim; and (iv) damages for the alleged tortious interference with contract, including punitive damages of at least $2 million. The Plaintiff is also seeking a declaratory judgment, claiming that he was not terminated as a director and should continue to hold a seat on the Company's Board of Directors.
Lease agreement [Member]
Commitments and Contingencies (Textual)
Term of lease agreement					60 months
Research Agreement [Member]
Commitments and Contingencies (Textual)
Research agreement expiration date		Feb. 28, 2018		Jan. 31, 2021
Installments of research agreement		$ 206,000
License agreement, description		The suspension is to continue until the date that is 30 days after expenses incurred by USC have been reimbursed by the Company.
Reserch cost and expenses				$ 550,000
License Agreement [Member]
Commitments and Contingencies (Textual)
License agreement, description	The Company is required to pay to USC 3% of net sales of licensed products or licensed processes used, leased or sold by the Company, 3% of revenues received by the Company from the sublicensing of patent rights and 23% of revenues (net of costs and expenses, including legal fees) received by the Company from final judgments in infringement actions respecting the patent rights licensed under the agreement.

Income Taxes (Details)

Income Taxes (Details) - USD ($)	Dec. 31, 2016	Dec. 31, 2015
Components of the deferred tax assets
Net operating losses	$ 22,000,000	$ 21,000,000
Less: valuation allowance	(22,000,000)	(21,000,000)
Net deferred tax assets

Income Taxes (Details Textual)

Income Taxes (Details Textual)	12 Months Ended
	Dec. 31, 2016USD ($)
Income Taxes (Textual)
Net operating loss carry-forwards	$ 65,552,428
Expiration period	Dec. 31, 2017

Subsequent Events (Details)

Subsequent Events (Details)	Mar. 09, 2017USD ($)Investor$ / sharesshares	Mar. 08, 2017USD ($)$ / sharesshares	Mar. 06, 2017$ / sharesshares	Feb. 01, 2017$ / sharesshares	Feb. 28, 2017$ / sharesshares	Feb. 27, 2017$ / shares	Jan. 31, 2017$ / sharesshares	Jan. 27, 2017USD ($)$ / sharesshares	Oct. 19, 2015shares	Apr. 15, 2015USD ($)	Dec. 31, 2015USD ($)$ / sharesshares	Feb. 13, 2017shares	Dec. 31, 2016shares	Sep. 30, 2015USD ($)
Subsequent Events (Textual)
Purchase of warrants | $											$ 914,220
Common stock issued upon debt conversion											3,323,230
Non convertible promissory note | $														$ 757,595
Common stock, shares issued											51,473,157		60,263,720
Warrant [Member]
Subsequent Events (Textual)
Purchase of warrants | $										$ 589,393
Warrants exercisable price per share | $ / shares											$ 1
Common stock issued upon debt conversion									75,288		1,350,000
Non convertible promissory note | $											$ 204,020			$ 377,500
Subsequent Event [Member]
Subsequent Events (Textual)
Warrants issued to purchase common stock							107,000
Warrants exercisable price per share | $ / shares							$ 0.50
Term of convertible note							5 years
Common stock issued upon debt conversion					64,800		107,000
Common stock, shares issued												336,000
Subsequent Event [Member] | Convertible Promissory Note [Member]
Subsequent Events (Textual)
Warrants exercisable price per share | $ / shares						$ 0.50		$ 0.50
Non convertible promissory note | $								$ 380,000
Subsequent Event [Member] | Warrant [Member]
Subsequent Events (Textual)
Warrants issued to purchase common stock			200,000	30,000	64,800
Warrants exercisable price per share | $ / shares	$ 0.50	$ 0.50	$ 0.50	$ 0.50	$ 0.50
Term of convertible note					5 years
Warrant term	5 years	5 years	5 years	5 years
Vesting of warrants				5,000	5,000
Subsequent Event [Member] | Investor [Member]
Subsequent Events (Textual)
Purchase of warrants | $	$ 100,000	$ 200,000						$ 200,000
Warrants issued to purchase common stock	200,000	400,000						400,000
Warrants exercisable price per share | $ / shares	$ 0.50	$ 0.50						$ 0.50
Term of convertible note	5 years	5 years
Common stock, conversion price | $ / shares	$ 0.50	$ 0.50				$ 0.50		$ 0.50
Non convertible promissory note | $								$ 380,000
Aggregating amount of debt | $								$ 19,000
Warrant term						5 years		5 years
Number of investors | Investor	2
Subsequent Event [Member] | Investor One [Member]
Subsequent Events (Textual)
Purchase of warrants | $	$ 150,000
Warrants issued to purchase common stock	300,000